Découvrez nos professeurs et professeures!

Paul R. Fortin

Médecin clinicien enseignant titulaire

Directeur(trice), Centre de recherche en arthrite (ARThrite)

Paul R. Fortin
Centre de recherche du CHU de Québec - Université Laval
Centre de recherche en arthrite (ARThrite)
Partager la fiche :
Ce profil n’a pas encore été complété.

Contribution à la recherche

Projets de recherche

  • Role of megakaryocytes in Systemic Lupus Erythematosus - Instituts de recherche en santé du Canada - Subvention Projet, co-chercheur - 2023-04-01 au 2028-03-31
  • Risk stratification and personalized therapy in lupus pregnancies - Instituts de recherche en santé du Canada - Subvention Projet, McGill University, co-chercheur - 2022-10-01 au 2027-09-30
  • Canada research chair in Innovate Systemic Autoimmune Rheumatic Disease - Instituts de recherche en santé du Canada - Chaires de recherche du Canada - Fonctionnement, chercheur principal - 2019-07-01 au 2026-06-30
  • Role of phosphatidylserine-specific phospholipase A1 (PLA1A) in the pathogenesis of rheumatic diseases - La société d'arthrite - Subvention stratégique de fonctionnement, co-chercheur - 2023-01-01 au 2025-12-31
  • Platelets and neutrophils: the two culprits mediating pain in inflammatory arthritis - Instituts de recherche en santé du Canada - Subvention Projet, co-chercheur - 2020-04-01 au 2025-03-31
  • FcgRI as a potential therapeutic target in inflammatory arthritis - La société d'arthrite, co-chercheur - 2022-01-01 au 2025-03-31
  • Megakaryocyte: a new player in systemic lupus erythematosus - Lupus Canada - Catalyst Grant Program, co-chercheur - 2022-09-01 au 2023-08-31
  • Hydroxychloroquine in systemic lupus - Instituts de recherche en santé du Canada - Subvention Projet, McGill University, co-chercheur - 2018-04-01 au 2023-03-31
  • The impact of antimalarial drugs in arthritis patients exposed to SARS-CoV-2- the CoVIRAL project - La société d'arthrite, chercheur principal - 2020-04-01 au 2023-03-31
  • COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune Diseases / La réponse immunitaire au vaccin contre la COVID-19 chez des patients immunosupprimés en raison de maladies auto-immunes - Ministère de la Santé et des Services sociaux, McGill University, co-chercheur - 2021-03-16 au 2023-03-31
  • Platelets and neutrophils: the two culprits mediating pain in inflammatory arthritis - La société d'arthrite, co-chercheur - 2020-01-01 au 2022-12-31
  • Booster dose of mRNA SARS-CoV-2 vaccine vs non mRNA vaccine for people living with systemic autoimmune rhumatic diseases without adequate humoral response post standard mRNA vaccination - Instituts de recherche en santé du Canada - Subvention de fonctionnement:Nouveaux besoins prioritaires en recherche sur la COVID-19, chercheur principal - 2021-12-01 au 2022-11-30
  • CompreHensive Analysis of Mitochondria in Pathogenesis of SLE (CHAMPS) - Lupus Research Alliance, chercheur principal - 2021-09-01 au 2022-08-31
  • Safety immUnogenicity of Covid-19 vaCcines in systEmic immunE mediated inflammatory Diseases (SUCCEED) - Agence de la santé publique du Canada, McGill University, co-chercheur - 2021-04-01 au 2022-03-31
  • Role of autotaxin bound to platelet-derived microparticles to development of vascular damage in arthritis. - Instituts de recherche en santé du Canada - Subvention de fonctionnement, co-chercheur - 2015-07-01 au 2021-06-30
  • Maladies Rhumatismales Autoimmunes Systémiques (MRAS) - Fondation du CHU de Québec, chercheur principal - 2020-12-15 au 2021-03-31
  • Understanding the pathogenesis of COVID-19 - Instituts de recherche en santé du Canada, Secrétariat Inter-Conseils (Canada) (CRSH, CRSNG, IRSC) - Subvention de fonctionnement : Possibilité de financement canadienne pour une intervention de recherche rapide contre la maladie à coronavirus 2019 (COVID-19), co-chercheur - 2020-03-01 au 2021-02-28

Publications

  • Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus, Stoll, T., Romero Diaz, J., Aranow, C., Van Vollenhoven, R., Kalunian, K., Maddison, P., Zoma, A., Ramsey-Goldman, R., Nived, O., Sturfelt, G., Manzi, S., Bruce, I.N., Dooley, M., Petri, M., Steinsson, K., Khamashta, M., Fessler, B., Alarcõn, G.S., Ginzler, E., Merrill, J., Rahman, A., Isenberg, D., Wallace, D.J., Hanly, J.G., Bernatsky, S., Clarke, A., Fortin, P.R., Gordon, C., Bae, S.C., Sanchez-Guerrero, J., Ibañez, D., Gladman, D.D., Urowitz, M., Arthritis Care and Research, 2014, 10.1002/acr.22299
  • Glomerular filtration rate predicts arterial events in women with systemic lupus erythematosus, Fortin, P.R., Scholey, J., Urowitz, M.B., Gladman, D.D., Landolt-Marticorena, C., Lou, W., Su, J., Reich, H.N., Aghdassi, E., Zhang, W., Rheumatology, 2011, 10.1093/rheumatology/keq383
  • The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository, Tektonidou, M.G., Zuily, S., Willis, R., Atsumi, T., Knight, J.S., Pons-Estel, G.J., Rodriguez, E., Petri, M., Fortin, P.R., Belmont, H.M., Tincani, A., de Jesus, G.R., Branch, D.W., Efthymiou, M., Ji, L., Gerosa, M., Ugarte, A., Pengo, V., Banzato, A., Rosa, R., Nascimento, I., Andrade, D., Barbhaiya, M., Erkan, D., Unlu, O., Arthritis Care and Research, 2019, 10.1002/acr.23584
  • Work disability in systemic lupus erythematosus, Fortin, P.R., Jiandong, S.U., Gignac, M.A.M., Dhanhani, A.M.A.L., Arthritis Care and Research, 2009, 10.1002/art.24347
  • Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis, Fortin, P.R., Wither, J.E., Peschken, C., Pope, J.E., Herzenberg, A., Scholey, J., Reich, H., Su, J., Landolt-Marticorena, C., Peeva, V., Morrison, S., Clarke, A.E., St.-Pierre, Y., Zhang, W., Aghdassi, E., Journal of Rheumatology, 2011, 10.3899/jrheum.100482
  • Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus, Sjöwall, C., Wetterö, J., Bruce, I.N., Stoll, T., Askanase, A., Peschken, C.A., Jacobsen, S., Kamen, D.L., Ramos-Casals, M., van Vollenhoven, R.F., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Zoma, A.A., Steinsson, K., Nived, O., Ramsey-Goldman, R., Manzi, S., Dooley, M.A., Mackay, M., Aranow, C., Khamashta, M., Petri, M., Chatham, W.W., Alarcón, G.S., Ginzler, E., Merrill, J.T., Rahman, A., Isenberg, D.A., Wallace, D.J., Hanly, J.G., Gordon, C., Bernatsky, S., Clarke, A.E., Sanchez-Guerrero, J., Fortin, P.R., Bae, S.-C., Romero-Diaz, J., Gladman, D.D., Urowitz, M.B., Jönsen, A., Padyukov, L., Dahle, C., Wirestam, L., Enocsson, H., Journal of Autoimmunity, 2020, 10.1016/j.jaut.2019.102340
  • Impact of disease activity and cumulative damage on the health of lupus patients, Danoff, D., Clarke, A.E., Fraenkel, L., Du Berger, R., Neville, C., Abrahamowicz, M., Fortin, P.R., Lupus, 1998, 10.1191/096120398678919813
  • The systemic lupus erythematosus tri-nation study: Absence of a link between health resource use and health outcome, Heaton, S., Rairie, J., Orsini-Dudin, M., Neville, C., Ferland, D., Trifero, M., Margonis, K., Panaritis, P., Panaritis, T., Esdaile, J.M., Grodzicky, T., Choquette, D., Goulet, J.R., Sutcliffe, N., Fortin, P.R., St Pierre, Y., Joseph, L., Penrod, J., Senécal, J.-L., Gordon, C., Isenberg, D.A., Manzi, S., Petri, M., Clarke, A.E., Rheumatology, 2004, 10.1093/rheumatology/keh229
  • Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatment, Bernatsky, S., Yelin, E.H., Wallace, D.J., Bae, S.C., Fortin, P.R., Ginzler, E., Petri, M., Romero-Diaz, J., Nived, O., Gladman, D., Urowitz, M.B., Tessier Cloutier, B., Foulkes, W., Ramsey-Goldman, R., Clarke, A.E., Chan, K., Lupus, 2018, 10.1177/0961203317713146
  • Platelets disseminate extracellular vesicles in lymph in rheumatoid arthritis, Boilard, É., Martel, C., Fortin, P.R., Wolberg, A.S., Brisson, A.R., Provost, P., Gilbert, C., McKenzie, S.E., Côté, F., Lévesque, T., Benmoussa, A., Michel, S., Milasan, A., Tan, S., Miszta, A., Allaeys, I., Cloutier, N., Melki, I., Tessandier, N., Arteriosclerosis, Thrombosis, and Vascular Biology, 2020, 10.1161/ATVBAHA.119.313698
  • Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosus, Devins, G.M., Cividino, A., Gladman, D., Smith, D., Rich, E., Choquette, D., Goulet, J.-R., Senécal, J.-L., Zummer, M., Beaulieu, A., Esdaile, J.M., Ensworth, S., Barr, S., Fortin, P.R., Dritsa, M., Da Costa, D., Clarke, A.E., Dobkin, P.L., Edworthy, S.M., Journal of Rheumatology, 2003
  • Anti-C1q antibodies in systemic lupus erythematosus, Petri, M., Magder, L.S., McGwin, G., Weisman, M.H., Brey, R., Pham, N., Hameed, S., Sigler, L., Franks, A.G., Steinsson, K., Rahman, A., Kamen, D.L., Inanc, M., Fessler, B.J., Lim, S.S., Callen, J.P., Jorizzo, J.L., Peschken, C., Stoll, T., Ginzler, E., Van Vollenhoven, R.F., Dooley, M.A., Maddison, P., Buyon, J.P., Jacobsen, S., Khamashta, M.A., Ruiz-Irastorza, G., Bernatsky, S., Zoma, A., Werth, V.P., Costner, M.I., Kalunian, K.C., Gladman, D.D., Urowitz, M.B., Manzi, S., Aranow, C.B., Clarke, A.E., Sanchez-Guerrero, J., Hanly, J.G., Bae, S.-C., Ramsey-Goldman, R., Wallace, D.J., Isenberg, D.A., Bruce, I.N., Fortin, P.R., Merrill, J.T., Gordon, C., Alarcón, G.S., Fang, H., Nived, O., Sturfelt, G., Truedsson, L., Orbai, A.-M., Lupus, 2015, 10.1177/0961203314547791
  • The rate and pattern of organ damage in late onset systemic lupus erythematosus, Sturfelt, G., Ramsey-Goldman, R., Petri, M., Nived, O., Manzi, S., Hanly, J., Gladman, D., Ginzler, E., Fortin, P., Buyon, J., Barr, S., Bae, S.-C., Aranow, C., Isenberg, D., Farewell, V., Maddison, P., Journal of Rheumatology, 2002
  • Connective tissue diseases: Mitochondria drive NETosis and inflammation in SLE, Fortin, P.R., Boilard, E., Nature Reviews Rheumatology, 2016, 10.1038/nrrheum.2016.24
  • The role of mitochondria in rheumatic diseases, Eric Boilard, Christian Lood, Paul R. Fortin, Bhargavi Duvvuri, Yann L. C. Becker, Nature Reviews Rheumatology, 2022, 10.1038/s41584-022-00834-z
  • Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study, Turner, K., Pepin, M.R., Cumin, J., Thorne, C., Sutton, E., Steen, V., Smith, D., Robinson, D., Rivière, S., Mekinian, A., Martin, T., Maurier, F., Manning, J., Jones, N., Varga, J., Korman, B., Hinchcliff, M., Herrick, A.L., Sobanski, V., Launay, D., Lambert, M., Hatron, P.-Y., Hachulla, E., Grange, C., Granel-Rey, B., Spiera, R., Gordon, J., Fortin, P.R., Wilcox, P., Dunne, J.V., Domsic, R., Gill, A., Denton, C., Chung, L., Rodriguez, E., Melchor, S., Martin, M., Fare, R., Carreira, P., Berthier, S., Hij, A., Farge-Bancel, D., Benzidia, I., Terrier, B., Régent, A., Paule, R., London, J., Cohen, P., Chaigne, B., Casadevall, M., Benmostefa, N., Roux, S., Masetto, A., Liang, P., Fernandes, A.J.D.B., Dagenais, P., Bruns, A., Boire, G., Bissonnette, L., Arsenault, G., Smets, P., André, M., Ikic, A., Albert, A., Agard, C., Wong-Rieger, D., Welling, J., Suarez-Almazor, M.E., Levis, B., Gyger, G., Steele, R.J., Schouffoer, A.A., Luna, D., Rodriguez Reyna, T.S., Portales, A., Pope, J., Marra, C., Khalidi, N., Larche, M., Kennedy, A.T., Johnson, S.R., Impens, A., Harel, D., Godard, D., Frech, T., Fligelstone, K., van den Ende, C., El-Baalbaki, G., Leite, C., Maia, A.C., Boutron, I., Wigley, F., Nielsen, K., Fortune, C., Sauve, M., Riggs, R., Nielson, W.R., Mouthon, L., Assassi, S., Mayes, M.D., van den Hoogen, F., Kafaja, S., Furst, D., Körner, A., Jang, Y., Hudson, M., Ells, C., Bartlett, S.J., Baron, M., Malcarne, V.L., Thombs, B.D., Roesch, S.C., Gottesman, K., Jewett, L.R., Fox, R.S., Gholizadeh, S., Carrier, M.-E., Kwakkenbos, L., Mills, S.D., Arthritis Care and Research, 2018, 10.1002/acr.23514
  • Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus, Fortin, P.R., Urowitz, M., Gladman, D., Ibanez, D., Bobba, R., Chang, E., Sarabi, Z.S., Arthritis Care and Research, 2005, 10.1002/art.21314
  • Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus, Merrill, J.T., Theriault, C., Thompson, K., Farewell, V., Peschken, C., Kamen, D., Lim, S., Petri, M., Ruiz-Irastorza, G., Fessler, B.J., Alarcoń, G.S., Kalunian, K., Mackay, M., Aranow, C., Ramos-Casals, M., Van Vollenhoven, R., Nived, O., Sturfelt, G., Ramsey-Goldman, R., Manzi, S., Khamashta, M., Steinsson, K., Bruce, I., Dooley, M.A., Sanchez-Guerrero, J., Romero-Dirz, J., Gladman, D., Fortin, P.R., Wallace, D.J., Rahman, A., Isenberg, D., Vasudevan, A., Bernatsky, S., Clarke, A., Gordon, C., Bae, S.-C., Su, L., Urowitz, M.B., Hanly, J.G., Annals of the Rheumatic Diseases, 2011, 10.1136/ard.2010.148502
  • Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus, Senécal, J.-L., Clarke, A.E., Fortin, P.R., Grover, S.A., Cé, R., Berger, R.D., Panaritis, C., Li, Y., Grodzicky, T., Abrahamowicz, M., Esdaile, J.M., Arthritis and Rheumatism, 2001, 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I
  • Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity, Inman, R.D., Pacheco-Tena, C., Fortin, P.R., Stone, M., Journal of Rheumatology, 2003
  • Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort, Fritzler, M.J., Fortin, P.R., Thorne, C., Smith, D., Rodriguez-Reyna, T.S., Robinson, D., Sutton, E., Masetto, A., Khalidi, N.A., Larché, M.J., Gyger, G., Hudson, M., Pope, J.E., Baron, M., Nevskaya, T., Rheumatology (United Kingdom), 2017, 10.1093/rheumatology/kex015
  • Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort, Bruce, I.N., Sanchez-Guerrero, J., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., van Vollenhoven, R.F., Zoma, A.A., Jönsen, A., Nived, O., Manzi, S., Alarcón, G.S., Mackay, M., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Gladman, D.D., Fortin, P., Dooley, M.A., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Buyon, J., Merrill, J.T., Wallace, D.J., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., Clarke, A.E., Urowitz, M.B., Hanly, J.G., Lunt, M., Parker, B., Little, J., Rheumatology (United Kingdom), 2018, 10.1093/rheumatology/kex444
  • Early medication use in new-onset rheumatoid arthritis may delay joint replacement: Results of a large population-based study, Bernatsky, S., Edworthy, S., Barnabe, C., Peschken, C., Maksymowych, W., Feldman, D., Hanly, J.G., Widdifield, J., Bombardier, C., Bessette, L., Fortin, P.R., Boire, G., Wang, Y., Lacaille, D., Beauchamp, M.-E., Abrahamowicz, M., Moura, C.S., Arthritis Research and Therapy, 2015, 10.1186/s13075-015-0713-3
  • Early Mortality in a Multinational Systemic Sclerosis Inception Cohort, Zochling, J., Youssef, P., Walker, J., Stevens, W., Sahhar, J., Roddy, J., Proudman, S., Thorne, C., Sutton, E., Smith, D., Rodriguez-Reyna, T.S., Robinson, D., Pope, J., Mathieu, J.-P., Masetto, A., Markland, J., Ligier, S., LeClercq, S., Larché, M., Khalidi, N., Kaminska, E., Jones, N., Hudson, M., Gyger, G., Grodzicky, T., Fritzler, M., Fortin, P.R., Docherty, P., Cabral, A.R., Abu-Hakima, M., Nikpour, M., Proudman, S., Huq, M., Joven, B.E., Carmona, L., Tatibouet, S., Rabusa, C., Stevens, W., Carreira, P., Baron, M., Hudson, M., Hao, Y., Arthritis and Rheumatology, 2017, 10.1002/art.40027
  • Quality of life in systemic lupus erythematosus patients during more and less active disease states: Differential contributors to mental and physical health, Clarke, A.E., Zummer, M., Smith, D., Gladman, D., Esdaile, J.M., Ensworth, S., Barr, S., Edworthy, S., Cividino, A., Beaulieu, A., Rich, E., Choquette, D., Goulet, J.-R., Senécal, J.-L., Fortin, P.R., Dritsa, M., Da Costa, D., Dobkin, P.L., Arthritis Care and Research, 1999, 10.1002/1529-0131(199912)12:6<401::aid-art8>3.0.co;2-f
  • Infections in the lupus patient: Perspectives on prevention, Fortin, P.R., Gold, W.L., Barber, C., Current Opinion in Rheumatology, 2011, 10.1097/BOR.0b013e3283476cd8
  • Approaches for estimating minimal clinically important differences in systemic lupus erythematosus, Aviña-Zubieta, J.A., Fortin, P.R., Yazdany, J., Rai, S.K., Arthritis Research and Therapy, 2015, 10.1186/s13075-015-0658-6
  • A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE, Newkirk, M.M., Fortin, P.R., Ligier, S., British Journal of Rheumatology, 1998
  • Distinct subtypes of microparticle-containing immune complexes are associated with disease activity, damage, and carotid intima-media thickness in systemic lupus erythematosus, Boilard, E., Laflamme, N., Simonyan, D., Eder, L., Aghdassi, E., Bissonnette, V., Cloutier, N., Fortin, P.R., Journal of Rheumatology, 2016, 10.3899/jrheum.160050
  • Clinical associations of the metabolic syndrome in systemic lupus erythematosus: Data from an international inception cohort, Bruce, I.N., Inanc, M., Peschken, C.A., Kamen, D.L., Lim, S., Ruiz-Irastorza, G., Kalunian, K.C., Van Vollenhoven, R.F., Ramos-Casals, M., MacKay, M., Aranow, C., Nived, O., Sturfelt, G.K., Zoma, A.A., Ramsey-Goldman, R., Khamashta, M.A., Manzi, S., Dooley, M.-A., Steinsson, K., Petri, M., Hanly, J.G., Fortin, P.R., Fessler, B.J., Alarcón, G.S., Merrill, J.T., Rahman, A., Isenberg, D.A., Ginzler, E.M., Bernatsky, S., Clarke, A.E., Wallace, D.J., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Bae, S.-C., Lunt, M., Gladman, D.D., Urowitz, M.B., Parker, B., Annals of the Rheumatic Diseases, 2013, 10.1136/annrheumdis-2012-202106
  • Quality assurance in Canada: Does insurance affect assurance?, Fortin, P.R., Journal of Rheumatology, 1992
  • Non-Hodgkin's lymphoma in systemic lupus erythematosus, Clarke, A., St. Pierre, Y., Sturfelt, G., Nived, O., Steinsson, K., Sibley, J., Bae, S.-C., Gordon, C., Barr, S., Edworthy, S., Fortin, P.R., Gladman, D., Urowitz, M., Ginzler, E., Manzi, S., Zoma, A., Cournoyer, D., Lachance, S., Joseph, L., Boivin, J.-F., Rajan, R., Ramsey-Goldman, R., Bernatsky, S., Annals of the Rheumatic Diseases, 2005, 10.1136/ard.2004.034504
  • Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study, Bernatsky, S., Boire, G., Fortin, P.R., Bessette, L., Gamache, P., Hudson, M., Jean, S., Clinical Rheumatology, 2017, 10.1007/s10067-017-3796-1
  • The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients, Fritzler, M.J., Mahler, M., Buyon, J., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., Van Vollenhoven, R.F., Zoma, A.A., Nived, O., Manzi, S., Alarcón, G.S., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Sanchez-Guerrero, J., Gladman, D.D., Fortin, P., Dooley, M.A., Bruce, I.N., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Merrill, J.T., Wallace, D.J., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., Urowitz, M.B., Hanly, J.G., St Pierre, Y., Clarke, A.E., Choi, M.Y., Lupus, 2017, 10.1177/0961203317692437
  • Reporting of Age Data in Clinical Trials of Arthritis: Deficiencies and Solutions, Chalmers, T.C., Minaker, K.L., Dear, K.B.G., Fortin, P.R., Rochon, P.A., Archives of Internal Medicine, 1993, 10.1001/archinte.1993.00410020091008
  • Vasculitis and malignancy, Fortin, P.R., Inflammatory Diseases of Blood Vessels, 2000, 10.1201/b14012
  • Clinical and serologic factors associated with lupus pleuritis, Peschken, C.A., Huber, A., Ramsey, S., Berkson, L., Baron, M., Scuccimarri, R., Duffy, K., Campillo, S., Chedéville, G., Albert, L., Cooper, G.S., Petty, R.E., Tucker, L.B., Hudson, M., Bernatsky, S., Clarke, A.E., Zummer, M., Urowitz, M.B., Gladman, D.D., Arbillaga, H., Smith, C.D., Pineau, C., Fortin, P.R., Pope, J.E., Silverman, E.D., Hitchon, C.A., Gelber, A.C., Mittoo, S., Journal of Rheumatology, 2010, 10.3899/jrheum.090249
  • The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes, Winer, J.B., Wallace, D.J., Waterhouse, E., Levine, S.R., Iverson, G., Hay, E.M., Harten, P., Fisk, J.D., Filley, C.M., Cornblath, W.D., Brey, R., Veilleux, M., Sanchez-Guerrero, J., Roberts, W.N., Petri, M., Moore, P.M., McCune, J., Lockshin, M.D., Lahita, R.G., West, S., Kozora, E., Hanly, J.G., Schur, P.H., Rogers, M.P., Khoshbin, S., Karlson, E.W., Glanz, B.I., Esdaile, J.M., Denburg, S., Denburg, J., Straaton, K.V., Alarcón, G.S., Isenberg, D., Gordon, C., Fortin, P.R., Lew, R.A., Bae, S.-C., Corzillius, M., Liang, M.H., Arthritis and Rheumatism, 1999, 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F
  • Do lupus disease activity measures detect clinically important change?, Liang, M.H., Fraenkel, L., Du Berger, R., Neville, C., Clarke, A.E., Abrahamowicz, M., Fortin, P.R., Journal of Rheumatology, 2000
  • Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies, Maria Laura Bertolaccini, Doruk Erkan, Hannah Cohen, Maria Efthymiou, Rohan Willis, Jason S. Knight, Ricard Cervera, Michelle A. Petri, Laura Andreoli, D. Ware Branch, Paul Fortin, Maria Gerosa, H. Michael Belmont, Guillermo Ruiz‐Irastorza, Vittorio Pengo, Maria Tektonidou, Danieli Andrade, Francesca Pregnolato, Cecilia B. Chighizola, Arthritis & Rheumatology, 2023, 10.1002/art.42459
  • Breast cancer in systemic lupus erythematosus, Bernatsky, S., Sturfelt, G., Dreyer, L., Barr, S.G., Criswell, L.A., Witte, T., Nived, O., Jacobsen, S., Hanly, J.G., Ruiz-Irastorza, G., Rahman, A., Isenberg, D., Bae, S.C., Peschken, C.A., Senécal, J.L., Dooley, M.A., Edworthy, S., Labrecque, J., Ginzler, E.M., Manzi, S., Petri, M., Wallace, D.J., Fortin, P.R., Gladman, D., Urowitz, M.B., Yelin, E., Hansen, J.E., Gordon, C., Foulkes, W., Wang, Y., Ramsey-Goldman, R., Clarke, A.E., Tessier Cloutier, B., Oncology (Switzerland), 2013, 10.1159/000353138
  • Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study, Farewell, V., Thompson, K., Douglas, J., Kalunian, K., Ramsey-Goldman, R., Nived, O., Sturfelt, G., Font, J., Van Vollenhoven, R., Ginzler, E., Aranow, C., Zoma, A., Khamashta, M., Manzi, S., Bruce, I., Steinsson, K., Fortin, P.R., Gladman, D., Dooley, M.A., Petri, M., Merrill, J.T., Bernatsky, S., Clarke, A., Alarcón, G.S., Isenberg, D., Wallace, D.J., Gordon, C., Bae, S.C., Sanchez-Guerrero, J., Urowitz, M.B., Hanly, J.G., Arthritis and Rheumatism, 2007, 10.1002/art.22305
  • Medication use in systemic lupus erythematosus (Journal of Rheumatology (2010) 38 (271-274)), Fortin, P.R., Peschken, C., Bernatsky, S., Journal of Rheumatology, 2012, 10.3899/jrheum.100414.C1
  • Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study, Farewell, V., Thompson, K., Theriault, C., Inanc, M., Peschken, C.A., Kamen, D.L., Lim, S., Ruiz-Irastorza, G., Kalunian, K.C., Van Vollenhoven, R.F., Ramos-Casals, M., Mackay, M., Aranow, C., Nived, O., Sturfelt, G.K., Zoma, A.A., Manzi, S., Ramsey-Goldman, R., Fessler, B.J., Alarcón, G.S., Khamashta, M.A., Dooley, M.A., Steinsson, K., Bruce, I.N., Gladman, D.D., Fortin, P.R., Petri, M., Rahman, A., Isenberg, D.A., Merrill, J.T., Ginzler, E.M., Clarke, A.E., Wallace, D.J., Romero-Diaz, J., Sanchez-Guerrero, J., Bae, S.-C., Gordon, C., Su, L., Urowitz, M.B., Hanly, J.G., Annals of the Rheumatic Diseases, 2012, 10.1136/annrheumdis-2011-201089
  • Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study, Levy, R.A., Rosa, R., Erkan, D., Nascimento, I.S., Willis, R., Atsumi, T., Knight, J.S., Cervera, R., Rodriguez, E., Petri, M., Fortin, P.R., Belmont, H.M., Andreoli, L., Branch, D.W., Cohen, H., Ugarte, A., Meroni, P.L., Ji, L., Pengo, V., Banzato, A., Tektonidou, M., Barbhaiya, M., Andrade, D., Sciascia, S., de Jesús, G.R., BJOG: An International Journal of Obstetrics and Gynaecology, 2019, 10.1111/1471-0528.15469
  • Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity, Fortin, P.R., Ferland, D., Belisle, P., Joseph, L., Clarke, A.E., Neville, C., Journal of Rheumatology, 2000
  • Patient expectations and total joint arthroplasty [1] (multiple letters), Katz, J.N., Fortin, P.R., Daltroy, L.H., Liang, M.H., Mahomed, N.N., Dieppe, P., Donovan, J., Woolhead, G., Journal of Rheumatology, 2003
  • The use of micronutrient supplements is not associated with better quality of life and disease activity in Canadian patients with systemic lupus erythematosus, Fortin, P.R., Wither, J., DaCosta, D., Peschken, C., Pope, J., Urowitz, M., Gladman, D., Pineau, C.A., Su, J., Landolt-Marticorena, C., Morrison, S., Aghdassi, E., Journal of Rheumatology, 2010, 10.3899/jrheum.090761
  • Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients, Gordon, C., Merrill, J., Zoma, A., Wallace, D.J., van Vollenhoven, R., Urowitz, M., Sturfelt, G., Steinsson, K., Sanchez-Guerrero, J., Ruiz-Irastorza, G., Romero-Diaz, J., Ramsey-Goldman, R., Rahman, A., Kalunian, K., Petri, M., Peschken, C., Nived, O., Manzi, S., Lim, S., Khamashta, M., Kamen, D., Jacobsen, S., Inanc, M., Hanly, J., Gladman, D., Ginzler, E., Fortin, P., Dooley, M.A., Clarke, A., Cervera, R., Buyon, J., Bruce, I., Bernatsky, S., Sang-Cheol, B., Askanase, A., Aranow, C., Allen, E., Sturgess, J., Isenberg, D., Arthritis Care and Research, 2018, 10.1002/acr.23252
  • Abetimus sodium for renal flare in systemic lupus erythematosus: Results of a randomized, controlled phase III trial, Zummer, M., Williams, G.W., Weaver, C., Vilardell-Tarres, M., Vijayan, A., Van Vollenhoven, R., Torres, A., Tindall, E.A., Surbeck, W., Sturfelt, G., Stevens, M.P., Spira, M., Spinowitz, B., Smith, D., Sisay, M., Sibilia, J., Sherrer, Y., Shergy, W.J., Schneider, M., Scarpa, N., Rothfield, N., Roth, A., Ramsey-Goldman, R., Quinet, R.J., Pogue, B.C., Petri, M., Neuwelt, C.M., Moritz, C., Moreland, L.W., Merrill, J.T., Mease, P.J., McKay, J., Martin, K., Manzi, S., Manion, C.V., Loveless, J., Lourie, S.H., Liebling, M., Kurtzman, N.A., Krishnan, M., Kovacs, C., Kivitz, A.J., Khamashta, M., Kenney, H.M., Kennedy, A., Katz, R., Kaplan, S., Kaplan, M.J., Kammer, G.M., Kalden, J.R., Jakes, J., Jaffer, A., Hura, C.E., Howard, P., Hiepe, F., Grossman, J., Granda, J., Gorevic, P., Ginzler, E., Gilkeson, G.S., Geppert, T., Fortin, P., Fondal, M., Espinoza, L.R., Ensworth, S., Emery, P., El-Shahawy, M.A., Edwards, M., Donohue, J., Desir, D., DeHoratius, R., Cush, J.J., Cronin, M.E., Condemi, J.J., Buyon, J., Brodeur, J., Bombardieri, S., Boling, E.P., Belmont, H.M., Becker, M.A., Ballou, S., Aranow, C., Appel, G.B., Aelion, J., Abeles, M., Joh, T., Linnik, M.D., Wallace, D.J., Furie, R.A., Tumlin, J.A., Cardiel, M.H., Arthritis and Rheumatism, 2008, 10.1002/art.23673
  • Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity, Fortin, P.R., Barr, S., Albert, L., Inman, R., Carette, S., Hitchon, C., Rich., E., Clarke, A., Bernatsky, S., Urowitz, M., Boire, G., Peschken, C., Hanly, J.G., Smith, C.D., Pineau, C.A., Pope, J., Gladman, D., Greenwood, C.M.T., Paterson, A.D., Hudson, T.J., Cooper, G.S., Claudio, J.O., Roslin, N., McKenzie, T., Lim, S., Cai, Y.-C., Wither, J., Arthritis Research and Therapy, 2008, 10.1186/ar2505
  • Evaluating the Construct of Damage in Systemic Lupus Erythematosus, Ian N. Bruce, Asad Zoma, Daniel J. Wallace, Heather Waldhauser, Ronald F. van Vollenhoven, Evelyne Vinet, Murray Urowitz, Zahi Touma, Elisabet Svenungsson, Jorge Sanchez‐Guerrero, Guillermo Ruiz‐Irastorza, Juanita Romero‐Diaz, John A. Reynolds, Rosalind Ramsey‐Goldman, Anisur Rahman, Michelle Petri, Christine A. Peschken, Eric F. Morand, Anselm Mak, S. Sam Lim, Alexandra Legge, Chynace Lambalgen, Diane L. Kamen, Kenneth Kalunian, Soren Jacobsen, John G. Hanly, Ellen M. Ginzler, Rebecca Gilman, Bernardo A. Pons‐Estel, Guillermo J. Pons‐Estel, Jessica A. English, Nathalie Costedoat‐Chalumeau, Sang‐Cheol Bae, Graciela S. Alarcón, Anca Askanase, Cynthia Aranow, Susan Manzi, Alexandre E. Voskuyl, Marta Mosca, Paul R. Fortin, Laurent Arnaud, Megan R. W. Barber, Ann E. Clarke, David Isenberg, Hermine I. Brunner, Dafna D. Gladman, Sindhu R. Johnson, Arthritis Care & Research, 2023, 10.1002/acr.24849
  • Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus, Gaffney, P.M., Moser, K.L., Altshuler, D., Daly, M.J., Vyse, T.J., Wong, A.K., Cunninghame Graham, D., Fortin, P.R., Rioux, J.D., Wither, J.E., Behrens, T.W., Plenge, R.M., Gates, C., Parkin, M., Guiducci, C., Burtt, N.P., Leon, J.M., Lessard, C.J., Hackett, R., Davies, L., Cotsapas, C., Graham, R.R., Nature Genetics, 2008, 10.1038/ng.200
  • Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study, Ellis, K., Duchek, D., Bustamante, L., Hebblethwaite, S., El-Baalbaki, G., Dyas, L., Culos-Reed, N., Turner, K.A., Rice, D.B., Østbø, N., Nordlund, J., Ayala, M.C., Wilcox, P., Thorne, C., Sutton, E., Steen, V., Sobanski, V., Roux, S., Rodriguez, E., Robinson, D., Rivière, S., Régent, A., Proudman, S., Olagne, L., Nikpour, M., Melchor, S., Mekinian, A., Martin, M., Marie, I., Manning, J., Launay, D., Khalidi, N., Kafaja, S., Fernandes, A.J.D.B., Jones, N., Hoa, S., Herrick, A.L., Hatron, P.-Y., Granel-Rey, B., Gordon, J., Fortin, P.R., Farge-Bancel, D., Dunogue, B., Dunne, J.V., Domsic, R., Denton, C., Correia, C., Chung, L., Chaigne, B., Carreira, P., Bruns, A., Bissonnette, L., Berthier, S., Bernstein, E.J., Albert, A., Agard, C., Suarez-Almazor, M.E., Schouffoer, A.A., Reyna, T.S.R., Rannou, F., Pope, J., Nguyen, C., Larche, M., Johnson, S.R., Hudson, M., Hinchcliff, M., Harel, D., Frech, T., van den Ende, C., Ells, C., Assassi, S., Riggs, R., Nielson, W.R., Mayes, M.D., Malcarne, V., Baron, M., Leite, C., Pérez, E., Gottesman, K., Fligelstone, K., Welling, J., Sauvé, M., Richard, M., Lewis, N., Guillot, G., Gietzen, A., Fortuné, C., Thombs, B.D., Benedetti, A., Varga, J., Mouthon, L., Bartlett, S.J., Patten, S., Negeri, Z., Carboni-Jiménez, A., Tao, L., Bourgeault, A., Harb, S., Gagarine, M., Carrier, M.-E., Henry, R.S., Kwakkenbos, L., Wu, Y., Journal of Psychosomatic Research, 2021, 10.1016/j.jpsychores.2020.110314
  • Osteoporosis in systemic lupus erythematosus: Factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density, Gladman, D.D., Ibanez, D., Fortin, P.J., Urowitz, M.B., Pineau, C.A., Lupus, 2004, 10.1191/0961203303lu1036oa
  • The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: A decision aid for development of entry criteria for clinical trials, Liang, M.H., Neville, C., Nayak, V., Du Berger, R., Fortin, P.R., Abrahamowicz, M., Journal of Rheumatology, 1998
  • Using Optimal Test Assembly Methods for Shortening Patient-Reported Outcome Measures: Development and Validation of the Cochin Hand Function Scale-6: A Scleroderma Patient-Centered Intervention Network Cohort Study, Mills, S.D., Gholizadeh, S., Fox, R.S., Pepin, M.R., Fedoruk, C., Thorne, C., Sutton, E., Steen, V., Smith, D., Schiopu, E., Robinson, D., Manning, J., Jones, N., Varga, J., Korman, B., Hinchcliff, M., Herrick, A.L., Spiera, R., Gordon, J., Wilcox, P., Dunne, J.V., Domsic, R., Gill, A., Denton, C., Chung, L., Carreira, P., Roux, S., Masetto, A., Liang, P., Fernandes, A.J.D.B., Dagenais, P., Bruns, A., Boire, G., Bissonnette, L., Arsenault, G., Ikic, A., Fortin, P., Albert, A., Wong-Rieger, D., Suarez-Almazor, M.E., Reyna, T.S.R., Portales, A., Pope, J., Marra, C., Khalidi, N., Larche, M., Kennedy, A.T., Johnson, S.R., Impens, A., Milette, K., Levis, B., Jewitt, L.R., Delisle, V.C., Gyger, G., Hudson, M., Godard, D., Frech, T., Nielsen, K., Fortune, C., Fligelstone, K., Persmann, J., El-Baalbaki, G., Leite, C., Maia, A.C., Boutron, I., Wigley, F., Riggs, R., Nielson, W.R., Assassi, S., Mayes, M.D., van den Hoogen, F., Gottesman, K., Kafaja, S., Furst, D., Steele, R.J., Jang, Y., Ells, C., Baron, M., Thombs, B.D., Welling, J., Schouffoer, A.A., Poole, J.L., van den Ende, C.H.M., Sauve, M., Malcarne, V.L., Khanna, D., Bartlett, S.J., Poiraudeau, S., Mouthon, L., Carrier, M.-E., Kwakkenbos, L., Harel, D., Levis, A.W., Arthritis Care and Research, 2016, 10.1002/acr.22893
  • Spatial modelling of lupus incidence over 40 years with changes in census areas, Fortin, P., Al-Maini, M., Rue, H., Brown, P., Li, Y., Journal of the Royal Statistical Society. Series C: Applied Statistics, 2012, 10.1111/j.1467-9876.2011.01004.x
  • Predictors of Unsuccessful Hydroxychloroquine Tapering and Discontinuation: Can We Personalize Decision‐Making in Systemic Lupus Erythematosus Treatment?, Sasha Bernatsky, Michal Abrahamowicz, Paul R. Fortin, Ann E. Clarke, Christine A. Peschken, John G. Hanly, Evelyne Vinet, Christian A. Pineau, Celline C. Almeida‐Brasil, Arthritis Care & Research, 2022, 10.1002/acr.24548
  • A conceptual framework for clinical trials in SLE and other multisystem diseases, Abrahamowicz, M., Esdaile, J.M., Fortin, P., Bae, S.-C., Corzillius, M., Liang, M.H., Lupus, 1999, 10.1191/096120399680411290
  • Assessment of the educational impact of an information leaflet on the knowledge of complications in systemic sclerosis, Michou, L., Fortin, P.R., Bessette, L., Brown, J.P., Beaudoin, C., Ikic, A., Joint Bone Spine, 2015, 10.1016/j.jbspin.2014.12.005
  • Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: Evidence of an association with interstitial lung disease and worse survival, Salazar, G., McNearney, T.A., Mayes, M.D., Assassi, S., Zochling, J., Walker, J., Stevens, W., Sahhar, J., Rischmueller, M., Proudman, S., Patterson, K., Roddy, J., Nash, P., Lester, S., Hill, C., Fritzler, M.J., Cabral, A.R., Rodriguez-Reyna, T.S., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., LeClercq, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Pope, J., Fritzler, M.J., Baron, M., Wang, M., Mayes, M.D., Assassi, S., Nikpour, M., Stevens, W., Walker, J., Proudman, S., Hudson, M., Wodkowski, M., Clinical and Experimental Rheumatology, 2015
  • The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients, Fritzler, M., Fortin, P.R., Thorne, C., Smith, D., Rodriguez-Reyna, T.S., Robinson, D., Sutton, E., Masetto, A., Khalidi, N., Larché, M., Pope, J., Gyger, G., Hudson, M., and the Canadian Scleroderma Research Group, Thombs, B.D., Baron, M., Hudson, M., Kwakkenbos, L., Levis, B., Clinical Rheumatology, 2017, 10.1007/s10067-016-3501-9
  • A controlled study of diffuse idiopathic skeletal hyperostosis: Clinical features and functional status, Esdaile, J.M., Chhem, R.K., Rosenberg, E., Gore, B., Watts, C.S., Joseph, L., Starr, M.R., Fitzcharles, M.-A., Fortin, P.R., Mata, S., Medicine, 1997, 10.1097/00005792-199703000-00003
  • Mortality related to cerebrovascular disease in systemic lupus erythematosus, Hanly, J.G., Ramsey-Goldman, R., Ensworth, S., Pope, J., Sibley, J., Edworthy, S., Zummer, M., Senécal, J.-L., Barr, S.G., Fortin, P.R., Urowitz, M., Gladman, D.D., Clarke, A., Bernatsky, S., Lupus, 2006, 10.1177/0961203306073133
  • Construction of a frailty index as a novel health measure in systemic lupus erythematosus, Hanly, J.G., Askanase, A., Peschken, C.A., Jacobsen, S., Kalunian, K.C., Kamen, D.L., Ramos-Casals, M., Nived, O., Jonsen, A., Van Vollenhoven, R.F., Inanc, M., Lim, S.S., Ruiz-Irastorza, G., MacKay, M., Aranow, C., Zoma, A.A., Manzi, S., Ramsey-Goldman, R., Dooley, M.A., Khamashta, M.A., Petri, M., Alarcon, G.S., Rahman, A., Isenberg, D.A., Bruce, I.N., Urowitz, M.B., Gladman, D.D., Fortin, P., Ginzler, E.M., Merrill, J.T., Clarke, A.E., Bernatsky, S., Wallace, D.J., Sanchez-Guerrero, J., Romero-Diaz, J., Gordon, C., Bae, S.-C., Andreou, P., Rockwood, K., Kirkland, S., Legge, A., Journal of Rheumatology, 2020, 10.3899/jrheum.181338
  • The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials, Wallace, D.J., Singh, A., Schneider, M.K., Ponticelli, C., Nived, O., Meyrier, A., Lundberg, I.E., Gordon, C.P., Finckh, A., Dooley, M.A., De Pablo, P., Crofford, L., Costenbader, K., Balow, J.E., St.Clair, E.W., Fortin, P., Schur, P.H., Liang, M.H., Arthritis and Rheumatism, 2006, 10.1002/art.21625
  • Mood disorders in systemic lupus erythematosus: Results from an international inception cohort study, Farewell, V., Thompson, K., Theriault, C., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., Van Vollenhoven, R.F., Zoma, A.A., Sturfelt, G.K., Nived, O., Manzi, S., Fessler, B.J., Alarcón, G.S., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Sanchez-Guerrero, J., Gladman, D.D., Fortin, P., Dooley, M.A., Bruce, I.N., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Merrill, J.T., Wallace, D.J., Clarke, A.E., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., Urowitz, M.B., Su, L., Hanly, J.G., Arthritis and Rheumatology, 2015, 10.1002/art.39111
  • Systemic lupus erythematosus disease activity index 2000 responder index-50: A reliable index for measuring improvement in disease activity, Gladman, D.D., Ibañez, D., Taghavi-Zadeh, S., Ziouzina, O., Ghanem, A., Eder, L., Chandran, V., Riddell, C., Toloza, S.M., Landolt, C., Fortin, P.R., Urowitz, M.B., Touma, Z., Journal of Rheumatology, 2011, 10.3899/jrheum.101080
  • Systematic review of validation studies of the use of administrative data to identify serious infections, Fortin, P.R., Lacaille, D., Barber, C., Arthritis Care and Research, 2013, 10.1002/acr.21959
  • Predictors of delay in starting radiation treatment for patients with early stage breast cancer, Freeman, C.R., Levinton, C., Zhang, G., Fortin, P.R., Ho, V., Benk, V., International Journal of Radiation Oncology Biology Physics, 1998, 10.1016/S0360-3016(98)00046-7
  • A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs), Baron, M., Bernatsky, S., Wang, M., Pineau, C.A., Bykerk, V., Fortin, P.R., Vinet, E., Hudson, M., Greenfield, J., PLoS ONE, 2017, 10.1371/journal.pone.0189840
  • Systemic lupus erythematosus, a disease associated with low levels of clusterin/ApoJ, an antiinflammatory protein, Fortin, P.R., Neville, C., Apostolakos, P., Newkirk, M.M., Journal of Rheumatology, 1999
  • Completeness of reporting of trials published in languages other than English: Implications for conduct and reporting of systematic reviews, Penna, A., Linde, K., Liberati, A., Le Lorier, J., Klassen, T., Jüni, P., Jadad, A.R., Fortin, P., Moher, D., Lancet, 1996, 10.1016/S0140-6736(96)90538-3
  • Discordance between patients and their physicians in the assessment of lupus disease activity: Relevance for clinical trials, Fortin, P.R., Neville, C., Yen, J.C., Lupus, 1999, 10.1191/096120399680411362
  • Subsets in systemic sclerosis: One size does not fit all, Youssef, P., Walker, J., Roddy, J., Zochling, J., Sahhar, J., Nikpour, M., Rodriguez-Reyna, T.S., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., Sutton, E., Masetto, A., Khalidi, N., Robinson, D., Markland, J., Baron, M., Pope, J., Wang, M., Fritzler, M.J., Stevens, W.M., Proudman, S.M., Hudson, M., Leclair, V., Journal of Scleroderma and Related Disorders, 2016, 10.5301/jsrd.5000212
  • Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort, Fritzler, M.J., Mahler, M., Buyon, J., Stoll, T., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., van Vollenhoven, R.F., Zoma, A.A., Nived, O., Manzi, S., Alarcón, G.S., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Gladman, D.D., Sanchez-Guerrero, J., Fortin, P.R., Dooley, M.A., Bruce, I.N., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Merrill, J.T., Wallace, D.J., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., Urowitz, M.B., Hanly, J.G., St. Pierre, Y., Clarke, A.E., Choi, M.Y., Arthritis Care and Research, 2019, 10.1002/acr.23712
  • Criteria for steroid-sparing ability of interventions in systemic lupus erythematosus: Report of a consensus meeting, Strand, V., St.Clair, E.W., Smolen, J., Schur, P., Roberts Jr., N., Phillips, C., Petri, M., Mosca, M., Moore, A., Mikdashi, J., Meyrier, A., McCune, J., Manzi, S., Lockshin, M., Koike, T., Khamashta, M., Kalden, J., Johnson, K., Illei, G., Gladman, D., Fischer-Betz, R., Esdaile, J.M., De Pablo, P., Crofford, L., Chehab, G., Buyon, J., Bombardieri, S., Bischoff-Ferrari, H., Benito-Garcia, E., Balow, J., Alarcón, G.S., Abrahamowicz, M., Schneider, M., Fortin, P., Liang, M.H., Arthritis and Rheumatism, 2004, 10.1002/art.20599
  • Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study, Farewell, V., Theriault, C., Askanase, A., Kamen, D.L., Peschken, C.A., Jacobsen, S., Kalunian, K.C., Inanc, M., Lim, S.S., Ramos-Casals, M., Ruiz-Irastorza, G., Mackay, M., Aranow, C., van Vollenhoven, R.F., Chatham, W., Alarcón, G.S., Khamashta, M.A., Jonsen, A., Nived, O., Manzi, S., Zoma, A.A., Ramsey-Goldman, R., Steinsson, K., Dooley, M.A., Ginzler, E.M., Petri, M., Bruce, I.N., Gladman, D.D., Fortin, P., Merrill, J.T., Rahman, A., Isenberg, D.A., Wallace, D.J., Clarke, A.E., Bernatsky, S., Sanchez-Guerrero, J., Romero-Diaz, J., Bae, S.-C., Gordon, C., Urowitz, M.B., Su, L., Li, Q., Hanly, J.G., Arthritis Care and Research, 2018, 10.1002/acr.23509
  • FcgRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus, Boilard, E., Fortin, P.R., Lacroix, S., Rondina, M.T., Machlus, K.R., McKenzie, S.E., Droit, A., Lood, C., Rauch, J., Patey, N., Lévesque, T., Laroche, A., Zufferey, A., Salem, D., Rowley, J.W., Campbell, R.A., Cloutier, N., Mailhot, B., Tessandier, N., Allaeys, I., Melki, I., Blood, 2020, 10.1182/blood.2020004974
  • Association of autoantibodies to nuclear lamin B1 with thromboprotection in systemic lupus erythematosus: Lack of evidence for a direct role of lamin B1 in apoptotic blebs, Raymond, Y., Brassard, N., Fortin, P., Hanly, J.G., Rauch, J., Senécal, J.-L., Dieudé, M., Arthritis and Rheumatism, 2002, 10.1002/art.10552
  • The role of stress in functional disability among women with systemic lupus erythematosus: A prospective study, Clarke, A.E., Esdaile, J.M., Danoff, D.S., Fortin, P.R., Pinard, L., Dobkin, P.L., Da Costa, D., Arthritis Care and Research, 1999, 10.1002/1529-0131(199904)12:2<112::aid-art6>3.0.co;2-2
  • Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus, Fortin, P.R., Urowitz, M.B., Gladman, D.D., Hirschfield, G.M., Mosko, J., Su, J., Aghdassi, E., Huang, D., Journal of Rheumatology, 2012, 10.3899/jrheum.110310
  • Epidemiologic studies of rheumatoid arthritis: Future directions, Fortin, P.R., Heath Jr., C.W., Journal of Rheumatology, 1992
  • Living with lupus: A prospective Pan-Canadian study, Clarke, A.E., Gladman, D., Zummer, M., Smith, D., Ensworth, S., Cividino, A., Beaulieu, A., Rich, E., Choquette, D., Goulet, J.-R., Senécal, J.-L., Esdaile, J.M., Barr, S., Edworthy, E., Fortin, P.R., Da Costa, D., Dobkin, P.L., Journal of Rheumatology, 2001
  • Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study, Turner, K., Thorne, C., Sutton, E., Steen, V., Smith, D., Robinson, D., Rivière, S., Maurier, F., Martin, T., Manning, J., Jones, N., Varga, J., Herrick, A.L., Sobanski, V., Grange, C., Granel-Rey, B., Spiera, R., Fortin, P.R., Wilcox, P., Domsic, R., Gill, A., Chung, L., Rodriguez, E., Berthier, S., Hij, A., Terrier, B., Roux, S., Smets, P., Ikic, A., Agard, C., Wong-Rieger, D., Welling, J., Suarez-Almazor, M.E., Levis, B., Schouffoer, A.A., Luna, D., Portales, A., Pope, J., Marra, C., Khalidi, N., Kennedy, A.T., Johnson, S.R., Impens, A., Harel, D., Godard, D., Frech, T., Fligelstone, K., van den Ende, C., El-Baalbaki, G., Leite, C., Maia, A.C., Boutron, I., Wigley, F., Nielsen, K., Riggs, R., Nielson, W.R., Mouthon, L., Assassi, S., van den Hoogen, F., Kafaja, S., Körner, A., Jang, Y., Hudson, M., Ells, C., Bartlett, S.J., Baron, M., Malcarne, V.L., Thombs, B.D., Mayes, M.D., Gottesman, K., Furst, D.E., Assassi, S., Merz, E.L., Roesch, S.C., Jewett, L.R., Gholizadeh, S., Mills, S.D., Carrier, M.-E., Kwakkenbos, L., Fox, R.S., Arthritis Care and Research, 2018, 10.1002/acr.23532
  • Corrigendum: Viewpoint: Response criteria for clinical trials in systemic lupus erythematosus (Lupus (1995) 4 (336-338)), Fortin, P.R., Liang, M.H., Lupus, 1997
  • Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: A pilot study, Fortin, P.R., Urowitz, M.B., Gladman, D.D., Clarke, S., Hillyer, L.M., Morrison, S., Ma, D.W.L., Aghdassi, E., Journal of Parenteral and Enteral Nutrition, 2011, 10.1177/0148607110386378
  • Validation of a systemic lupus activity questionnaire (SLAQ) for population studies, Fortin, P.R., Liang, M.H., Partridge, A.J., Wright, E.A., Ramsey-Goldman, R., Rivest, C., Daltroy, L.H., Karlson, E.W., Lupus, 2003, 10.1191/0961203303lu332oa
  • Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: Data from an international inception cohort, Buyon, J., Stoll, T., Kalunian, K., Aranow, C., Van Vollenhoven, R., Font, J., Maddison, P., Nived, O., Sturfelt, G., Zoma, A., Ramsey-Goldman, R., Khamashta, M., Manzi, S., Bruce, I., Dooley, M.A., Petri, M., Steinsson, K., Alarcon, G., Merrill, J., Ginzler, E., Isenberg, D., Wallace, D., Hanly, J., Gordon, C., Bernatsky, S., Clarke, A., Bae, S., Sanchez-Guerrero, J., Fortin, P., Ibañez, D., Gladman, D., Urowitz, M.B., Lupus, 2007, 10.1177/0961203307081113
  • Association of smoking with cutaneous manifestations in systemic lupus erythematosus, Pineau, C.A., Belisle, P., Huber, A.M., Chédeville, G., Silverman, E., Esdaile, J., Arbillaga, H., Hudson, M., Tucker, L., Pope, J., Zummer, M., Smith, C.D., Mittoo, S., Hitchon, C., Fortin, P.R., Clarke, A.E., Joseph, L., Bernatsky, S., Peschken, C.A., Bourré-Tessier, J., Arthritis Care and Research, 2013, 10.1002/acr.21966
  • Health Insurance Coverage and Clinical Outcomes in Women with Breast Cancer, Epstein, A.M., Kohler, B.A., Ayanian, J.Z., Fortin, P., Benk, V., Hamilton, V., New England Journal of Medicine, 1993, 10.1056/NEJM199312303292716
  • Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus, Maddison, P., Petri, M., Stoll, T., Aranow, C., Van Vollenhoven, R.F., Ramos, M., Kalunian, K., Zoma, A., Dooley, M.A., Ramsey-Goldman, R., Manzi, S., Steinsson, K., Bruce, I.N., Sturfelt, G., Nived, O., Khamashta, M., Ginzler, E., Merrill, J.T., Alarcón, G.S., Rahman, A., Isenberg, D., Wallace, D.J., Hanly, J.G., Fortin, P.R., Bernatsky, S., Clarke, A., Gordon, C., Sanchez-Guerrero, J., Bae, S.C., Ibañez, D., Gladman, D., Urowitz, M.B., Arthritis Care and Research, 2010, 10.1002/acr.20122
  • Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus, Sylvain G Bourgoin, Paul R Fortin, Eric Boilard, Chenqi Zhao, Anne-Claire Duchez, Anne-Sophie Julien, Stephan Hasse, Lupus Science & Medicine, 2022, 10.1136/lupus-2021-000605
  • The Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis: A National Multidisciplinary Stakeholder Project, Inman, R., Zummer, M., Thomson, G., Starr, M., Shojania, K., Shanner, L., Savage, L., Russell, A.S., Olszynski, W.P., Mulholland, K., Mosher, D., Klinkhoff, A.V., Karsh, J., Fortin, P., Dimond, S., Choquette, D., Bykerk, V., Boonen, A., Rahman, P., Gladman, D., Maksymowych, W.P., Journal of Rheumatology, 2007
  • Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus, Magder, L.S., McGwin Jr., G., Weisman, M.H., Brey, R., Pham, N., Fang, H., Hameed, S., Sigler, L., Franks Jr., A.G., Steinsson, K., Rahman, A., Kamen, D.L., Inanc, M., Fessler, B.J., Lim, S.S., Callen, J.P., Jorizzo, J.L., Peschken, C., Stoll, T., Ginzler, E., Van Vollenhoven, R.F., Dooley, M.A., Maddison, P., Buyon, J.P., Jacobsen, S., Khamashta, M.A., Ruiz-Irastorza, G., Bernatsky, S., Zoma, A., Werth, V.P., Costner, M., Kalunian, K., Gladman, D., Urowitz, M., Manzi, S., Aranow, C., Clarke, A., Sánchez-Guerrero, J., Hanly, J.G., Bae, S.-C., Ramsey-Goldman, R., Sturfelt, G., Nived, O., Wallace, D.J., Isenberg, D., Bruce, I.N., Fortin, P.R., Merrill, J.T., Gordon, C., Alarcõn, G.S., Orbai, A.-M., Petri, M., Arthritis and Rheumatism, 2012, 10.1002/art.34473
  • The systemic lupus erythematosus tri-nation study: Longitudinal changes in physical and mental well-being, Heaton, S., Rairie, J., Orsini-Dudin, M., Neville, C., Ferland, D., Trifero, M., Margonis, K., Panaritis, P., Panaritis, T., Clarke, A.E., Esdaile, J.M., Grodzicky, T., Choquette, D., Goulet, J.-R., Sutcliffe, N., Fortin, P.R., Pineau, C., St. Pierre, Y., Joseph, L., Penrod, J.R., Senecal, J.-L., Gordon, C., Isenberg, D.A., Manzi, S., Petri, M., Panopalis, P., Rheumatology, 2005, 10.1093/rheumatology/keh580
  • A hot spot for systemic lupus erythematosus, but not for psoriatic arthritis, identified by spatial analysis suggests an interaction between ethnicity and place of residence, Fortin, P.R., Gladman, D.D., Su, J., Li, L., Lee, J.J.Y., Brown, P., Al-Maini, M., Jeyalingam, T., Arthritis and Rheumatism, 2013, 10.1002/art.37897
  • Response criteria for clinical trials in systemic lupus erythematosus, Fortin, P.R., Liang, M.H., Lupus, 1995, 10.1177/096120339500400502
  • Underestimating the value of women: Assessing the indirect costs of women with systemic lupus erythematosus, Esdaile, J.M., Grodzicky, T., Choquette, D., Goulet, J.R., Sutcliffe, N., Fortin, P.R., Senecal, J.-L., Gordon, C., Isenberg, D.A., Manzi, S., Petri, M.A., St. Pierre, Y., Penrod, J., Clarke, A.E., Journal of Rheumatology, 2000
  • Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: Data from North and South America, Spain and Portugal, Alarcón, G.S., Wolfe, F., Costenbader, K.H., Karlson, E.W., Liu, J.M., Gonzalez, E., Navarro, I., Roldán, J., Gentiletti, S.B., Segami, M.I., Acevedo, E.M., Weisman, M., Esteva-Spinetti, M.H., Portela, M., Santos, M.J., Calvo-Alén, J., Fortin, P.R., Vilá, L.M., Durán-Barragán, S., Manni, J.A., Silvariño, R., De La Torre, I.G., Molina, J.F., Ramirez, L.A., Burgos, P.I., Neira, O., Catoggio, L.J., Velozo, E., Souza, A.W.S., Saurit, V., Onetti, L., Marques, C.D., Scherbarth, H., Berbotto, G.A., Duarte, A., Marcos, J.C., García, M.A., Clarke, A., Bernatsky, S., Shinjo, S.K., Borba, E.F., Bonfa, E., Iglesias-Gamarra, A., Romero-Díaz, J., Sánchez-Guerrero, J., Pons-Estel, B.A., Lupus, 2009, 10.1177/0961203309105590
  • The importance of patient expectations in predicting functional outcomes after total joint arthroplasty, Katz, J.N., Fossel, A.H., Fortin, P.R., Daltroy, L.H., Cook, E.F., Liang, M.H., Mahomed, N.N., Journal of Rheumatology, 2002
  • Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort, Stoll, T., Askanase, A., Peschken, C., Jacobsen, S., Kamen, D.L., Ramos-Casals, M., Van Vollenhoven, R., Inanç, M., Kalunian, K.C., Lim, S., Ruiz-Irastorza, G., Zoma, A., Steinsson, K., Nived, O., Sturfelt, G., Ramsey-Goldman, R., Manzi, S., Dooley, M., Aranow, C., Khamashta, M., Bruce, I.N., Petri, M., Fessler, B.F., Alarcón, G.S., Ginzler, E., Merrill, J., Rahman, A., Isenberg, D., Wallace, D.J., Hanly, J.G., Gordon, C., Bernatsky, S., Clarke, A., Sanchez-Guerrero, J., Fortin, P.R., Bae, S.C., Romero-Diaz, J., Su, J., Anderson, N.M., Gladman, D.D., Urowitz, M.B., Lupus Science and Medicine, 2016, 10.1136/lupus-2015-000143
  • Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin, Fortin, P.R., Neville, C., Tannenbaum, M., Rauch, J., Thrombosis and Haemostasis, 1998, 10.1055/s-0037-1615392
  • Fine particulate air pollution and systemic autoimmune rheumatic disease in two Canadian provinces, Joseph, L., Bélisle, P., Edworthy, S., van Donkelaar, A., Fortin, P.R., Clarke, A.E., Hudson, M., Martin, R.V., Brand, A., Svenson, L.W., Barnabe, C., Smargiassi, A., Bernatsky, S., Environmental Research, 2016, 10.1016/j.envres.2015.12.021
  • Neuropsychiatric events in systemic lupus erythematosus: A longitudinal analysis of outcomes in an international inception cohort using a multistate model approach, Farewell, V., Askanase, A., Kamen, D.L., Peschken, C.A., Jacobsen, Sø., Kalunian, K.C., Inanc, M., Lim, S., Ruiz-Irastorza, G., MacKay, M., Aranow, C., Van Vollenhoven, R.F., Alarcón, G.S., Jönsen, A., Manzi, S., Ramsey-Goldman, R., Dooley, M.A., Ginzler, E.M., Petri, M., Bruce, I.N., Gladman, D.D., Fortin, P.R., Merrill, J.T., Rahman, A., Isenberg, D.A., Wallace, D.J., Clarke, A.E., Bernatsky, S., Sanchez-Guerrero, J., Romero-Diaz, J., Bae, S.-C., Gordon, C., Urowitz, M.B., Hanly, J.G., Annals of the Rheumatic Diseases, 2019, 10.1136/annrheumdis-2019-216150
  • Management of osteoarthritis of the hip and knee, Fortin, P., Liang, M.H., New England Journal of Medicine, 1991, 10.1056/NEJM199107113250210
  • The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis, Bertolaccini, M.L., Mackie, I., Efthymiou, M., Cohen, H., Erkan, D., Banzato, A., Rosa, R., Nascimento, I., Atsumi, T., Rodriguez-Pinto, I., Rodriguez, E., Petri, M., Fortin, P.R., Nalli, C., Levy, R.A., Branch, D.W., Chighizola, C., Ugarte, A., Tektonidou, M.G., Andrade, D., Krilis, S., Pengo, V., Willis, R., Sciascia, S., Thrombosis Research, 2019, 10.1016/j.thromres.2019.01.010
  • Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus, Zummer, M., Weaver, C., Wallace, D., Vilardell-Tarres, M., Vijayan, A., Varga, J., Van Vollenhoven, R., Tumlin, J., Torres, A., Tindall, E.A., Surbeck, W., Sturfelt, G., Stevens, M.P., Stern, S., Staud, R., Spira, M., Spinowitz, B., Smith, D., Sibilia, J., Sherrer, Y., Shergy, W.J., Sewell, L.K., Schousboe, J.T., Schneider, M., Scarpa, N., Rothfield, N., Rosenblatt, S.G., Ramsey-Goldman, R., Quinet, R.J., Poque, B.C., Petri, M., Neuwelt, M.C., Moreland, L.W., Merrill, J., McKay, J., Martin, K., Manzi, S., Loveless, J., Lourie, S.H., Lindberg, J.S., Liebling, M., Kurtzman, N.A., Krishnan, M., Kivitz, A.J., Khamashta, M., Kenney, H.M., Katz, R., Kaplan, S., Kaplan, J., Kanick, K., Kammer, G.M., Kalunian, K.C., Kalden, J.P., Jakes, J., Jaffer, A., Ingelmo, M., Hura, C., Hill, M., Howard, P., Hiepe, F., Grossman, J., Granda, J.L., Gluck, O.S., Ginzler, E., Gilkeson, G.S., Gil-Aguado, A., Geppert, T., Genovese, M.C., Furie, R.A., Fortin, P., Fondal, M., Finkel, T.H., Espinoza, L.R., Emery, P., El-Shahawy, M.A., Edwards, M., Desir, D., DeHoratius, R., Cush, J.J., Cronin, M.E., Condemi, J.J., Carteron, N.L., Cardiel, M.H., Buyon, J.P., Brelsford, W.G., Bombardieri, S., Boling, E.P., Bohan, A., Belmont, M.H., Becker, N., Becker, M.A., Ballou, S., Aranow, C., Appel, G., Alarcón-Segovia, D., Joh, T., Hurley, F.L., Strand, V., Heilbrunn, K.R., Hu, J.Z., Linnik, M.D., Arthritis and Rheumatism, 2005, 10.1002/art.20980
  • Development and initial validation of a self-assessed lupus organ damage instrument, Wolfe, F., Alarcón, G.S., Michaud, K., Liu, J., Sanchez, M.L., Fortin, P.R., Chakravarty, E., Katz, R.S., Shaver, T.S., Hanly, J.G., Navarro, I., Fraser, P., Schur, P., Massarotti, E., Coblyn, J., Bermas, B., Turner-Stokes, T., Karlson, E.W., Manzi, S., Elliott, J., Petri, M., Perez-Rodriguez, M.T., Ruiz-Garcia, S., Khamashta, M., Costenbader, K.H., Arthritis Care and Research, 2010, 10.1002/acr.20193
  • Headache in systemic lupus erythematosus: Results from a prospective, international inception cohort study, Farewell, V., Thompson, K., Theriault, C., Jacobsen, S., Kamen, D.L., Peschken, C.A., Kalunian, K.C., Lim, S.S., Inanc, M., Ruiz-Irastorza, G., Mackay, M., Aranow, C., Ramos-Casals, M., Van Vollenhoven, R.F., Zoma, A.A., Nived, O., Sturfelt, G.K., Manzi, S., Ramsey-Goldman, R., Khamashta, M.A., Steinsson, K., Dooley, M.A., Bruce, I.N., Alarcõn, G.S., Fessler, B.J., Gladman, D.D., Fortin, P.R., Petri, M., Merrill, J.T., Rahman, A., Isenberg, D.A., Ginzler, E.M., Wallace, D.J., Bernatsky, S., Clarke, A.E., Romero-Diaz, J., Sanchez-Guerrero, J., Bae, S.-C., Gordon, C., O'Keeffe, A.G., Urowitz, M.B., Hanly, J.G., Arthritis and Rheumatism, 2013, 10.1002/art.38106
  • Tuberculosis of the skull, Fortin, P.R., Lebel, F., Miller, M.A., American Journal of Roentgenology, 1990, 10.2214/ajr.155.5.2120959
  • Work factors are associated with workplace activity limitations in systemic lupus erythematosus, Fortin, P.R., Su, J., Beaton, D.E., Gignac, M.A., Dhanhani, A.M., Rheumatology (United Kingdom), 2014, 10.1093/rheumatology/keu242
  • Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects, Salazar, G., McNearney, T.A., Zochling, J., Sahhar, J., Rischmueller, M., Patterson, K., Roddy, J., Nash, P., Lester, S., Hill, C., Fritzler, M.J., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., LeClercq, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Baron, M., Pope, J., Wang, M., Tatibouet, S., Mayes, M.D., Assassi, S., Nikpour, M., Stevens, W., Walker, J., Proudman, S., Hudson, M., Wodkowski, M., Autoimmunity, 2015, 10.3109/08916934.2015.1077231
  • A study of manufacturer-supported trials of nonsteroidal anti- inflammatory drugs in the treatment of arthritis, Chalmers, T.C., Minaker, K.L., Felson, D.T., Fortin, P.R., Simms, R.W., Gurwitz, J.H., Rochon, P.A., Archives of Internal Medicine, 1994, 10.1001/archinte.154.2.157
  • Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus, Hanly, J.G., Askanase, A., Peschken, C.A., Jacobsen, S., Kalunian, K., Kamen, D.L., Ramos-Casals, M., Nived, O., Jonsen, A., van Vollenhoven, R.F., Inanc, M., Lim, S.S., Ruiz-Irastorza, G., Mackay, M., Aranow, C., Zoma, A.A., Steinsson, K., Manzi, S., Ramsey-Goldman, R., Dooley, M.A., Khamashta, M.A., Petri, M., Alarcón, G.S., Rahman, A., Isenberg, D., Bruce, I.N., Urowitz, M.B., Gladman, D.D., Fortin, P., Ginzler, E.M., Merrill, J., Clarke, A.E., Bernatsky, S., Wallace, D.J., Sanchez-Guerrero, J., Romero-Diaz, J., Gordon, C., Bae, S.-C., Andreou, P., Rockwood, K., Kirkland, S., Legge, A., Arthritis and Rheumatology, 2019, 10.1002/art.40859
  • The Purinergic Receptor P2X4 Promotes Th17 Activation and the Development of Arthritis, Fawzi Aoudjit, Jean Sévigny, Paul R. Fortin, Mabrouka Salem, Amna Abderrazak, Chenqi Zhao, Chakib Hamoudi, The Journal of Immunology, 2022, 10.4049/jimmunol.2100550
  • Small changes in outpatient lupus activity are better detected by clinical instruments than by laboratory tests, Danoff, D., Abrahamowicz, M., Fortin, P.R., Journal of Rheumatology, 1995
  • Responsiveness and sensitivity to change of SLE disease activity measures, Stucki, G., Fortin, P., Corzillius, M., Lupus, 1999, 10.1191/096120399680411416
  • Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration, Boilard, E., Fortin, P.R., Lacroix, S., Newman, P.J., Flick, M.J., Khan, W.I., Nieswandt, B., Cote, F., McKenzie, S.E., Flamand, L., Italiano, J.E., Rondina, M.T., Poirier, G., Zhi, H., Melki, I., Tessandier, N., Becker, Y., Levesque, T., Zufferey, A., Mailhot, B., Machlus, K.R., Marcoux, G., Allaeys, I., Cloutier, N., Proceedings of the National Academy of Sciences of the United States of America, 2018, 10.1073/pnas.1720553115
  • Comprehensive radiographic evaluation of diffuse idiopathic skeletal hyperostosis: Development and interrater reliability of a scoring system, Esdaile, J.M., Joseph, L., Fortin, P.R., Chhem, R.K., Mata, S., Seminars in Arthritis and Rheumatism, 1998, 10.1016/S0049-0172(98)80041-3
  • Thrombosis and inflammation: A question in need of an answer, Fortin, P.R., Landolt-Marticorena, C., Bobba, R., Journal of Rheumatology, 2005
  • Vasculitides associated with malignancy, Fortin, P.R., Current Opinion in Rheumatology, 1996, 10.1097/00002281-199601000-00005
  • Development and Acceptability of a Patient Decision Aid for Pain Management in Juvenile Idiopathic Arthritis: The JIA Option Map, Décary, S., Gmuca, S., Weiss, J.E., Connelly, M., Brinkman, W., Fortin, P.R., Gibbon, M., Ueffing, E., Cavallo, S., Stringer, E., El Hindi, T., Ragusa, M., Sivakumar, A., Sirois, A., Sachs, H., Boyd, A., Berbatovci, F., Couchman, D., Stinson, J., Tugwell, P., Li, L.C., Gaboury, I., Cohen, J.S., Morgan, E.M., Proulx, L., Duffy, C.M., Huber, A.M., Toupin-April, K., Patient, 2020, 10.1007/s40271-020-00458-z
  • Effect of menopause on the modified Rodnan skin score in systemic sclerosis, Fritzler, M., Fortin, P.R., Smith, D., Thorne, C., Gyger, G., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masetto, A., LeClercq, S., Kaminska, E., Docherty, P., Larché, M., Khalidi, N., Jones, N., Robinson, D., Markland, J., Pope, J., Baron, M., Pineau, C.A., Hudson, M., Bernatsky, S., Vinet, T., Arthritis Research and Therapy, 2014, 10.1186/ar4587
  • Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study, Farewell, V., Theriault, C., Askanase, A., Kamen, D.L., Peschken, C.A., Jacobsen, S., Kalunian, K.C., Inanc, M., Lim, S.S., Ramos-Casals, M., Ruiz-Irastorza, G., Mackay, M., Aranow, C., van Vollenhoven, R.F., Svenungsson, E., Alarcón, G.S., Nived, O., Jonsen, A., Khamashta, M.A., Manzi, S., Zoma, A.A., Ramsey-Goldman, R., Steinsson, K., Dooley, M.A., Ginzler, E.M., Petri, M., Bruce, I.N., Gladman, D.D., Rahman, A., Merrill, J.T., Fortin, P.R., Isenberg, D.A., Wallace, D.J., Clarke, A.E., Bernatsky, S., Sanchez-Guerrero, J., Romero-Diaz, J., Bae, S.-C., Gordon, C., Urowitz, M.B., Su, L., Li, Q., Hanly, J.G., Arthritis and Rheumatology, 2020, 10.1002/art.41070
  • Cancer risk in systemic lupus: An updated international multi-centre cohort study, Clarke, A.E., St. Pierre, Y., Sibley, J., Dreyer, L., McCarthy, T., El-Gabalawy, H., Ensworth, S., Pope, J.E., Zummer, M., Senécal, J.-L., Patel, N.M., Sturfelt, G., Criswell, L.A., Barr, S., Askanase, A., Steinsson, K., Kamen, D.L., Aranow, C., Witte, T., Rahman, A., Isenberg, D., Ruiz-Irastorza, G., Nived, O., Alarcón, G.S., Hanly, J.G., Peschken, C.A., Dooley, M.A., Gordon, C., Jacobsen, S., Edworthy, S., Wallace, D.J., Bae, S.-C., Yelin, E., Ginzler, E., Fortin, P.R., Gladman, D., Urowitz, M.B., Manzi, S., Zoma, A., Petri, M., Boivin, J.-F., Joseph, L., Labrecque, J., Ramsey-Goldman, R., Bernatsky, S., Journal of Autoimmunity, 2013, 10.1016/j.jaut.2012.12.009
  • An international cohort study of cancer in systemic lupus erythematosus, Clarke, A., Ramsey-Goldman, R., St. Pierre, Y., McCarthy, T., El-Gabalawy, H., Pope, J., Ensworth, S., Hanly, J., Zummer, M., Senécal, J.L., Alarcón, G., Sturfelt, G., Nived, O., Aranow, C., Dooley, M.A., Steinsson, K., Rahman, A., Isenberg, D., Sibley, J., Bae, S.C., Gordon, C., Barr, S., Edworthy, S., Petri, M., Fortin, P.R., Gladman, D., Urowitz, M., Ginzler, E., Manzi, S., Zoma, A., Rajan, R., Joseph, L., Boivin, J.F., Bernatsky, S., Arthritis and Rheumatism, 2005, 10.1002/art.21029
  • Vasculitis and malignancy, Fortin, P.R., Inflammatory Diseases of Blood Vessels, 2016
  • Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus, Fortin, P.R., Scholey, J.W., Landolt-Marticorena, C., Wither, J., Cattran, D.C., Herzenberg, A.M., Su, J., Fan, S.C.P., Lou, W., Hladunewich, M.A., Bargman, J.M., Gladman, D.D., Urowitz, M.B., Reich, H.N., Kidney International, 2011, 10.1038/ki.2010.525
  • Duration of Postvaccination Neutralizing Antibodies to SARS‐CoV‐2 and Medication Effects: Results from the Safety and Immunogenicity of COVID‐19 Vaccination in Systemic Immune‐Mediated Inflammatory Diseases Cohort Study, Sasha Bernatsky, Elizabeth Turnbull, Nadine Lalonde, Charles N. Bernstein, Daniel Pereira, Jennifer L. F. Lee, Luck Lukusa, Ines Colmegna, Maggie J. Larché, Louis Flamand, Anne‐Claude Gingras, Dawn M. E. Bowdish, Gilles Boire, Paul R. Fortin, Vinod Chandran, Carol Hitchon, Roya M. Dayam, Rami Habib, ACR Open Rheumatology, 2024, 10.1002/acr2.11697
  • Surveillance of systemic autoimmune rheumatic diseases using administrative data, Joseph, L., Bergeron, L., Lagace, C., Bélisle, P., Smith, M., Fortin, P.R., Clarke, A.E., Pineau, C.A., Peschken, C., Badley, E., Hudson, M., Hanly, J.G., Lix, L., Bernatsky, S., Rheumatology International, 2011, 10.1007/s00296-010-1591-2
  • Posterior Reversible Encephalopathy Syndrome: An Emerging Disease Manifestation in Systemic Lupus Erythematosus, Fortin, P.R., Urowitz, M.B., Gladman, D.D., Leclerc, R., Barber, C.E., Seminars in Arthritis and Rheumatism, 2011, 10.1016/j.semarthrit.2011.07.001
  • SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice, Louis Flamand, Jiannis Ragoussis, Shu-Huang Chen, Sally Lee, Anne-Marie Roy, Melissa Zwaig, Haig Hugo Vrej Djambazian, Jose Hector Galvez, Jose Avila Cervantes, Ju-Ling Liu, Paul Fortin, Émile Lacasse, Ana Claudia dos Santos Pereira Andrade, Leslie Gudimard, Isabelle Dubuc, Annie Gravel, Julian Daniel Sunday Willett, Communications Biology, 2024, 10.1038/s42003-024-05878-3
  • Unpacking early work experiences of young adults with rheumatic disease: An examination of absenteeism, job disruptions, and productivity loss, Gignac, M.A.M., Shiff, N.J., Fortin, P.R., Beaton, D., Badley, E., Jetha, A., Arthritis Care and Research, 2015, 10.1002/acr.22601
  • Altered expression of TNF-α signaling pathway proteins in systemic lupus erythematosus, Wither, J.E., Fortin, P.R., Urowitz, M.B., Gladman, D.D., Yu, X.-Q., Yang, X., Li, T., Landolt-Marticorena, C., Zhu, L.-J., Journal of Rheumatology, 2010, 10.3899/jrheum.091123
  • The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus, Sturfelt, G., Snaith, M., Sanchez-Guerrero, J., Petri, M., Nived, O., Kalunian, K., Isenberg, D.A., Hanly, J.G., Gordon, C., Ginzler, E., Fortin, P., Goldsmith, C.H., Urowitz, M.B., Gladman, D.D., Arthritis and Rheumatism, 1997, 10.1002/art.1780400506
  • SARS-CoV-2 evolution in the absence of selective immune pressures, results in antibody resistance, interferon suppression and phenotypic differences by lineage, Louis Flamand, Jiannis Ragoussis, Shu-Huang Chen, Sally Lee, Anne-Marie Roy, Melissa Zwaig, Haig Hugo Vrej Djambazian, Jose Hector Galvez, Jose Avila Cervantes, Ju-Ling Liu, Paul Fortin, Émile Lacasse, Ana Claudia dos Santos Pereira Andrade, Leslie Gudimard, Isabelle Dubuc, Annie Gravel, Julian Daniel Sunday Willett, 2023, 10.1101/2023.01.16.523994
  • Validation of a meta-analysis: The effects of fish oil in rheumatoid arthritis, Sperling, R.I., Chalmers, T.C., Beckett, L.A., Wright, E.A., Liang, M.H., Lew, R.A., Fortin, P.R., Journal of Clinical Epidemiology, 1995, 10.1016/0895-4356(95)00028-3
  • Rheumatoid arthritis prevalence in Quebec, Joseph, L., Feldman, D.E., Bergeron, L., Belisle, P., Chetaille, A.L., Jean, S., Bessette, L., Fortin, P.R., Boire, G., Pineau, C.A., Hudson, M., Dekis, A., Bernatsky, S., BMC Research Notes, 2014, 10.1186/1756-0500-7-937
  • Quality assurance and audit: Lessons from North America, Fortin, P., Liang, M.H., Annals of the Rheumatic Diseases, 1991, 10.1136/ard.50.7.522
  • Outcomes of total hip and knee replacement: Preoperative functional status predicts outcomes at six months after surgery, Katz, J.N., Sledge, C.B., Mahomed, N., Fossel, A.H., Bélisle, P., Partridge, A.J., Phillips, C., Ferland, D., Tanzer, M., Liang, M.H., Joseph, L., Clarke, A.E., Fortin, P.R., Arthritis and Rheumatism, 1999, 10.1002/1529-0131(199908)42:8<1722::AID-ANR22>3.0.CO;2-R
  • The prevalence and accuracy of self-reported history of 11 autoimmune diseases, Inman, R., Carette, S., Senecal, J.-L., Rich, E., Boire, G., Barr, S., Zummer, M., Hitchon, C., Peschken, C., Clarke, A., Smith, C.D., Hanly, J., Urowitz, M., Gladman, D., Pope, J., Greenwood, C.M.T., Hudson, T., Fortin, P.R., Bernatsky, S., Claudio, J.O., Mckenzie, T., Wither, J., Cooper, G.S., Journal of Rheumatology, 2008
  • The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus, Zoma, A., Symmons, D., Sturfelt, G., Snaith, M., Sanchez-Guerrero, J., Richter, M., Petri, M., Nived, O., Maddison, P., Kalunian, K., Jones, J., Isenberg, D., Hay, E., Hanly, J., Bombardieri, S., Bacon, P., Urowitz, M., Liang, M., Fortin, P., Goldsmith, C., Ginzler, E., Gladman, D., Arthritis and Rheumatism, 1996, 10.1002/art.1780390303
  • Autoantibodies in systemic lupus erythematosus target mitochondrial RNA, Boilard, E., Fortin, P.R., Rauch, J., Rollet-Labelle, E., Benk-Fortin, H., Loignon, R.-C., Julien, A.-S., Allaeys, I., Marcoux, G., Becker, Y., Frontiers in Immunology, 2019, 10.3389/fimmu.2019.01026
  • Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity, Fortin, P.R., Ferland, D., Abrahamowicz, M., Chang, E.R., Journal of Rheumatology, 2002
  • Mortality in systemic lupus erythematosus, Ramsey-Goldman, R., Clarke, A., St. Pierre, Y., McCarthy, T., El-Gabalawy, H., Sibley, J., Rahman, A., Edworthy, S., Pope, J., Ensworth, S., Hanly, J., Zummer, M., Senécal, J.-L., Alarcón, G., Steinsson, K., Sturfelt, G., Nived, O., Dooley, M.-A., Aranow, C., Zoma, A., Isenberg, D., Bae, S.-C., Gordon, C., Barr, S., Petri, M., Fortin, P.R., Urowitz, M., Gladman, D.D., Ginzler, E., Manzi, S., Joseph, L., Boivin, J.-F., Bernatsky, S., Arthritis and Rheumatism, 2006, 10.1002/art.21955
  • Burden of autoantibodies and association with disease activity and damage in systemic lupus erythematosus, Urowitz, M.B., Fortin, P.R., Ibañez, D., Toloza, S.M., Tulloch-Reid, D., Gladman, D.D., Touma, Z., Clinical and Experimental Rheumatology, 2010
  • 2013 american college of rheumatology/european league against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: Data from the canadian scleroderma research group, Baron, M., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., Leclercq, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Pope, J., Tatibouet, S., Fritzler, M., Hudson, M., Alhajeri, H., Arthritis Care and Research, 2015, 10.1002/acr.22451
  • "What do you expect? You're just getting older": A comparison of perceived osteoarthritis-related and aging-related health experiences in middle- and older-age adults, Badley, E.M., Fortin, P.R., Mahomed, N., Wright, J.G., Hawker, G., Davis, A.M., Gignac, M.A.M., Arthritis Care and Research, 2006, 10.1002/art.22338
  • Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus, Pope, J.E., Nevskaya, T., Fortin, P.R., Hitchon, C., Hudson, M., Bernatsky, S., Zummer, M., Arbillaga, H., Smith, C.D., Pineau, C., Silverman, E., Peschken, C.A., Wong-Pak, A., George, A., Arthritis Care and Research, 2017, 10.1002/acr.22922
  • The use of alternative medical therapies in patients with systemic lupus erythematosus, Clarke, A.E., Esdaile, J.M., Grodzicky, T., Choquette, D., Goulet, J.R., Sutcliffe, N., Fortin, P.R., Penrod, J., Joseph, L., Pierre, Y.S.T., Senécal, J.-L., Gordon, C., Isenberg, D.A., Manzi, S., Petri, M.A., Moore, A.D., Arthritis and Rheumatism, 2000, 10.1002/1529-0131(200006)43:6<1410::AID-ANR27>3.0.CO;2-U
  • When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study, Sasha Bernatsky, Valeria Valerio, Elizabeth Turnbull, Lindsay Hracs, Joshua Quan, Sophie Roux, Hugues Allard-Chamard, Janet Gunderson, Nadine Lalonde, John Kim, Jenna Benoit, Diane Lacaille, Charles N. Bernstein, Mark S. Silverberg, Tania H. Watts, Daniel Pereira, Dawn P. Richards, Jennifer L.F. Lee, Luck Lukusa, Ines Colmegna, Roya M. Dayam, Anne-Claude Gingras, Gilles Boire, Maggie J. Larché, Paul R. Fortin, J. Antonio Avina-Zubieta, Gilaad G. Kaplan, Carol A. Hitchon, Vinod Chandran, Dawn M.E. Bowdish, The Journal of Rheumatology, 2024, 10.3899/jrheum.2023-1214
  • Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies, Hanly, J.G., Docherty, P., Senécal, J.-L., Fortin, I., Rauch, J., Fortin, P.R., Greer, W.L., Koren, S., Chopra, N., Journal of Rheumatology, 2002
  • The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-β2-glycoprotein I antibodies, Fortin, P.R., Chang, E.R., Subang, R., Belisle, P., Joseph, L., Solymoss, S., Kassis, J., Rauch, J., Neville, C., Rheumatology, 2006, 10.1093/rheumatology/kel050
  • A functional marked point process model for lupus data, Fortin, P., Abrahamowicz, M., Ramsay, J.O., Fok, C.C.T., Canadian Journal of Statistics, 2012, 10.1002/cjs.11136
  • Accumulation of coronary artery disease risk factors over three years: Data from an international inception cohort, Stoll, T., Kalunian, K., Aranow, C., Van Vollenhoven, R., Font, J., Maddison, P., Nived, O., Sturfelt, G., Zoma, A., Ramsey-Goldman, R., Khamashta, M., Manzi, S., Bruce, I., Dooley, M.A., Petri, M., Steinsson, K., Alarcón, G.S., Merrill, J., Ginzler, E., Isenberg, D., Wallace, D., Hanly, J., Gordon, C., Bernatsky, S., Clarke, A., Bae, S., Sanchez-Guerrero, J., Fortin, P., Ibañez, D., Gladman, D., Urowitz, M.B., Arthritis Care and Research, 2008, 10.1002/art.23353
  • Development and Validation of the Body Concealment Scale for Scleroderma, Fortin, P., Thorne, C., LeClercq, S., Mittoo, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Docherty, P., Kaminska, E., Jones, N., Robinson, D., Khalidi, N.A., Sutton, E., Masetto, D.A., Pope, J., Thombs, B.D., Wigley, F.M., Heinberg, L., Haythornthwaite, J.A., Baron, M., Hudson, M., Steele, R.J., Körner, A., Rumsey, N., Harcourt, D., Kwakkenbos, L., Malcarne, V.L., Jewett, L.R., Arthritis Care and Research, 2016, 10.1002/acr.22819
  • Psychosocial contributors to mental and physical health in patients with systemic lupus erythematosus, Clarke, A.E., Danoff, D.S., Esdaile, J.M., Joseph, L., Fortin, P.R., Dobkin, P.L., Arthritis and Rheumatism, 1998, 10.1002/art.1790110105
  • Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort, Stoll, T., Askanase, A., Peschken, C.A., Jacobsen, S., Kamen, D.L., Ramos-Casals, M., van Vollenhoven, R., Ỉnanç, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Zoma, A.A., Steinsson, K., Jönsen, A., Nived, O., Ramsey-Goldman, R., Manzi, S., Dooley, M.A., Aranow, C., Khamashta, M.A., Bruce, I.N., Petri, M.A., Chatham, W.W., Alarcón, G.S., Ginzler, E., Merrill, J.T., Rahman, A., Isenberg, D.A., Wallace, D.J., Hanly, J.G., Gordon, C., Bernatsky, S., Clarke, A.E., Sanchez-Guerrero, J., Fortin, P.R., Bae, S.-C., Romero-Diaz, J., Su, J., Farewell, V., Gladman, D.D., Urowitz, M.B., Arthritis and Rheumatology, 2020, 10.1002/art.41392
  • Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis, Fritzler, M., Fortin, P.R., Thorne, C., Smith, D., Rodriguez-Reyna, T.S., Robinson, D., Sutton, E., Masetto, A., Khalidi, N., Pope, J., Larché, M., Gyger, G., Hudson, M., Larché, M., Baron, M., Lorenzi, S., Fritzler, M.J., Hudson, M., Thabane, L., Cheng, J., Adachi, J.D., Li, G., Clinical and Experimental Rheumatology, 2017
  • Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus, Landolt-Marticorena, C., Wither, J., Boutros, P.C., Fortin, P.R., Scholey, J., Urowitz, M., Gladman, D., Reich, H., Lou, W., Morrison, S., Prokopec, S.D., Li, T., Rheumatology (Oxford, England), 2015, 10.1093/rheumatology/keu326
  • Familial antiphospholipid syndrome and HLA-DRB gene associations, Fortin, P.R., Kassis, J., Rauch, J., Busque, L., Hudson, N., Arthritis and Rheumatism, 1997, 10.1002/art.1780401030
  • Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians, Fortin, P.R., Ferland, D., Abrahamowicz, M., Chang, E., Journal of Clinical Epidemiology, 2002, 10.1016/S0895-4356(01)00509-1
  • The Presence of Multiple Prothrombotic Risk Factors Is Associated with a Higher Risk of Thrombosis in Individuals with Anticardiolipin Antibodies, Fortin, P.R., Busque, L., Kassis, J., Séguin, C., Ibrahim, R., Chang, E., Neville, C., Rauch, J., Herr, A.-L., Hudson, M., Journal of Rheumatology, 2003
  • 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: Data from a large international inception cohort, Ramsey-Goldman, R., Stoll, T., Van Vollenhoven, R., Font, J., Aranow, C., Petri, M., Kalunian, K., Dooley, M.A., Manzi, S., Steinsson, K., Sturfelt, G., Nived, O., Bruce, I., Khamashta, M., Ginzler, E., Wallace, D.J., Merrill, J., Rahman, A., Isenberg, D., Hanly, J.G., Bernatsky, S., Clarke, A., Gordon, C., Bae, S.-C., Fortin, P., Gladman, D., Urowitz, M., Dyer, A., Wu, P., Lertratanakul, A., Arthritis Care and Research, 2014, 10.1002/acr.22291
  • Sharing ongoing care with primary care physicians opens up opportunity for timelier and earlier care by rheumatologists for patients with new inflammatory polyarthritis, Michou, L., Fortin, P.R., Bessette, L., Julien, A.-S., Nguyen, P., Journal of Rheumatology, 2018, 10.3899/jrheum.170494
  • Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus, Abrahamowicz, M., Gupta, S., Buyon, J., Mittleman, B., Manzi, S., Illei, G.G., Fortin, P.R., Ward, M., Dore, B.T., Costenbader, K., Simard, J.F., Liang, M.H., Endocrine, Metabolic and Immune Disorders - Drug Targets, 2009, 10.2174/187153009787582388
  • Medication use in systemic lupus erythematosus, Clarke, A.E., Arbillaga, H.O., Smith, C.D., Zummer, M., Hudson, M., Pope, J.E., Gladman, D.D., Urowitz, M.B., Pineau, C.A., Fortin, P.R., Peschken, C., Bernatsky, S., Journal of Rheumatology, 2011, 10.3899/jrheum.100414
  • Fine particulate air pollution, nitrogen dioxide, and systemic autoimmune rheumatic disease in Calgary, Alberta, Joseph, L., Bélisle, P., Edworthy, S., Fortin, P.R., Clarke, A.E., Hudson, M., Bertazzon, S., Brand, A., Svenson, L., Barnabe, C., Kaplan, G.G., Johnson, M., Smargiassi, A., Bernatsky, S., Environmental Research, 2015, 10.1016/j.envres.2015.05.007
  • The 1000 Canadian faces of lupus: Determinants of disease outcome in a large multiethnic cohort, Huber, A., Ramsey, S., Berkson, L., Baron, M., Scuccimarri, R., Duffy, K., Campillo, S., Chedéville, G., Petty, R., Tucker, L., Hitchon, C., Inman, R.D., Carette, S., Albert, L., Cooper, G.S., Hudson, M., Bernatsky, S., Clarke, A., Zummer, M., Urowitz, M., Gladman, D.D., Arbillaga, H.O., Smith, C.D., Pineau, C., Fortin, P.R., Pope, J.E., Silverman, E., Katz, S.J., Peschken, C.A., Journal of Rheumatology, 2009, 10.3899/jrheum.080912
  • Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach, Clarke, A.E., Farewell, V., Theriault, C., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., van Vollenhoven, R.F., Zoma, A.A., Jönsen, A., Nived, O., Manzi, S., Alarcón, G.S., Mackay, M., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Sanchez-Guerrero, J., Gladman, D.D., Fortin, P.R., Bruce, I.N., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Wallace, D.J., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., St. Pierre, Y., Urowitz, M.B., Su, L., Hanly, J.G., Barber, M.R.W., Arthritis Care and Research, 2018, 10.1002/acr.23480
  • Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus, Fortin, P.R., Urowitz, M.B., Gladman, D.D., Scholey, J., Bargman, J., Reich, H., Lou, W., Su, J., Aghdassi, E., Yip, J., Journal of Rheumatology, 2010, 10.3899/jrheum.091028
  • Transancestral mapping and genetic load in systemic lupus erythematosus, Vyse, T.J., Gaffney, P.M., Graham, R.R., Wakeland, E.K., Harley, J.B., Kimberly, R.P., Alarcón-Riquelme, M.E., Silverman, E.D., Behrens, T.W., Schanberg, L.E., Tsao, B.P., Sivils, K.L., Jacob, C.O., Criswell, L.A., Rönnblom, L., Syvänen, A.-C., Gregersen, P.K., Rioux, J.D., Oksenberg, J.R., Bhangale, T., Wither, J.E., Weisman, M.H., Wallace, D.J., Vilá, L.M., Vasconcelos, C., Tusié-Luna, T., Truedsson, L., Toloza, S.M.A., Thompson, S.D., Svenungsson, E., Sjöwall, C., Seldin, M.F., Scorza, R., Scherbarth, H.R., Aguilar-Salinas, C.A., Sabio, J.M., Russell, L.P., Reveille, J.D., Ramsey-Goldman, R., Raj, P., Pope, J., Pons-Estel, B.A., Pineau, C.A., Petri, M., Ortego-Centeno, N., Orozco, L., Niewold, T.B., Nath, S.K., Moctezuma, J.F., Miranda, P., Merrill, J.T., McWilliams, D.R., McCune, J.M., Martín, J., Maradiaga-Ceceną, M.A., Li, Q.-Z., Lauwerys, B.R., Laustrup, H., Kovács, L., Kottyan, L.C., Kaufman, K.M., Karp, D.R., Kamen, D.L., Kallenberg, C.G.M., James, J.A., Huggins, J.L., Guthridge, J.M., Gunnarsson, I., Gladman, D.D., Gilkeson, G.S., De La Torre, I.G., Garcýá, M.A., Frostegård, J., Freedman, B.I., Fortin, P.R., Esquivel-Valerio, J.A., Endreffy, E., Edberg, J.C., Doria, A., De La RúaFigueroa, I., Da Silva, B.M., D'Alfonso, S., Dahlqvist, S.R., Cucho-Venegas, J.M., Cervera, R., Catoggio, L., Cardiel, M.H., Brunner, H.I., Brown, E.E., Bijl, M., Berbotto, G.A., Bengtsson, A.A., Baca, V., Babini, A.M., Alarcón, G.S., Acevedo-Vásquez, E.M., Almlöf, J.C., Sandling, J.K., Morris, D.L., Croker, J.A., Ramos, P.S., Howard, T.D., Marion, M.C., Comeau, M.E., Kelly, J.A., Graham, D.S.C., Ainsworth, H.C., Langefeld, C.D., Nature Communications, 2017, 10.1038/ncomms16021
  • Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: Results from an international inception cohort study, Merrill, J.T., Thompson, K., Qi, Q., Douglas, J., Kalunian, K., Font, J., Zoma, A., Khamashta, M., Petri, M., Alarcón, G.S., Sanchez-Guerrero, J., Nived, O., Sturfelt, G., Van Vollenhoven, R., Ramsey-Goldman, R., Wallace, D.J., Aranow, C., Ginzler, E., Bruce, I.N., Steinsson, K., Manzi, S., Fortin, P.R., Gladman, D., Bernatsky, S., Clarke, A., Dooley, M.A., Isenberg, D., Bae, S.C., Gordon, C., Farewell, V., Siannis, F., Urowitz, M.B., Hanly, J.G., Arthritis and Rheumatism, 2008, 10.1002/art.23218
  • A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome, Kovacs, M.J., Gent, M., Wilson, S., Yacura, W., Costantini, L., Green, D., Forgie, M., Geerts, W., Clarke, A., Kearon, C., Anderson, D., Fortin, P., Laskin, C., Douketis, J., Hirsh, J., Denburg, J., Julian, J., Ginsberg, J.S., Crowther, M.A., New England Journal of Medicine, 2003, 10.1056/NEJMoa035241
  • American college of rheumatology criteria at inception, and accrual over 5 years in the slicc inception cohort, Stoll, T., Aranow, C., Ramos-Casals, M., Van Vollenhoven, R., Manzi, S., Khamashta, M., Zoma, A., Ramsey-Goldman, R., Steinsson, K., Fessler, B., Alarcón, G.S., Dooley, M.A., Sturfelt, G., Nived, O., Merrill, J.T., Bruce, I.N., Petri, M., Ginzler, E., Wallace, D.J., Rahman, A., Isenberg, D., Hanly, J.G., Fortin, P.R., Bernatsky, S., Clarke, A.E., Bae, S.-C., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Ibañez, D., Gladman, D.D., Urowitz, M.B., Journal of Rheumatology, 2014, 10.3899/jrheum.130704
  • Adaptation and validation of the rheumatoid arthritis quality of life scale for use in Canada, Fortin, P.R., Le Comte, M., McKenna, S., Whalley, D., Neville, C., Journal of Rheumatology, 2001
  • An assessment of disease flare in patients with systemic lupus erythematosus: A comparison of BILAG 2004 and the flare version of SELENA, Rahman, A., Gordon, C., Wallace, D.J., Urowitz, M., Sturfelt, G., Ramsey-Goldman, R., Petri, M., Nived, O., Merrill, J.T., Khamashta, M., Kalunian, K., Inanc, M., Hanly, J.G., Gladman, D.D., Ginzler, E.M., Fortin, P.R., Dooley, M.A., Bruce I.n., Aranow, C., Alarcón, G.S., D'Cruz, D., Farewell, V., Allen, E., Isenberg, D.A., Annals of the Rheumatic Diseases, 2011, 10.1136/ard.2010.132068
  • Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype, Fritzler, M.J., Cabral, A.R., Rodriguez-Reyna, T.S., Abu-Hakima, M., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., LeClercq, S., Grodzicky, T., Ligier, S., Hudson, M., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Baron, M., Pope, J., Baron, M., Milo, J., Bentow, C., Wang, M., Mahler, M., Choi, M.Y., Hudson, M., Fritzler, M.J., Autoimmunity Reviews, 2018, 10.1016/j.autrev.2018.01.006
  • Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria, Laurence S. Magder, Andrew G. Franks, Jr, Kristjan Steinsson, Anisur Rahman, Diane L. Kamen, Murat Inanç, Sam Lim, Jeffery P. Callen, Joseph L. Jorizzo, Christine Peschken, Thomas Stoll, Ellen Ginzler, Ronald van Vollenhoven, Mary Anne Dooley, Jill P. Buyon, Søren Jacobsen, Munther Khamashta, Sasha Bernatsky, Asad Zoma, Victoria P. Werth, Ken Kalunian, Dafna D. Gladman, Murray Urowitz, Susan Manzi, Cynthia Aranow, Ann E. Clarke, Jorge Sanchez‐Guerrero, John G. Hanly, Sang‐Cheol Bae, Rosalind Ramsey‐Goldman, Ola Nived, Daniel Wallace, David Isenberg, Ian N. Bruce, Paul R. Fortin, Joan T. Merrill, Caroline Gordon, Graciela S. Alarcón, Daniel W. Goldman, Michelle Petri, Arthritis Care & Research, 2021, 10.1002/acr.24263
  • The longterm effect of early intensive treatment of seniors with rheumatoid arthritis: A comparison of 2 population-based cohort studies on time to joint replacement surgery, Bernatsky, S., Feldman, D., Hanly, J.G., Bombardier, C., Bessette, L., Fortin, P.R., Boire, G., Beauchamp, M.-E., Huang, A., Michael Paterson, J., Abrahamowicz, M., Wang, Y., Moura, C.S., Widdifield, J., Journal of Rheumatology, 2016, 10.3899/jrheum.151156
  • The Impact of Pain and Itch on Functioning and Health-Related Quality of Life in Systemic Sclerosis: An Exploratory Study, Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masseto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Pope, J., Nielson, W.R., Baron, M., Hudson, M., Racine, M., Journal of Pain and Symptom Management, 2016, 10.1016/j.jpainsymman.2015.12.314
  • Practice variations in the diagnosis, monitoring, and treatment of systemic lupus erythematosus in Canada, Urowitz, M.B., Peschken, C., Gladman, D.D., Fortin, P.R., Vandermeer, B., Bernatsky, S., Bissonauth, A., Keeling, S.O., Journal of Rheumatology, 2018, 10.3899/jrheum.171307
  • Response to Middleton KR et als. Yoga and SLE, Bernatsky, S., Neville, A., Neville, C., Fortin, P.R., Clarke, A.E., Da Costa, D., Pineau, C.A., Lee, J., Complementary Therapies in Medicine, 2019, 10.1016/j.ctim.2019.02.019
  • The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity, Strand, V., St.Clair, E.W., Smolen, J., Schur, P., Roberts Jr., N., Phillips, C., Petri, M., Mosca, M., Moore, A., Mikdashi, J., Meyrier, A., McCune, J., Manzi, S., Lockshin, M., Koike, T., Khamashta, M., Kalden, J., Johnson, K., Iking-Konert, C., Isenberg, D., Illei, G., Gordon, C., Gladman, D., Fischer-Betz, R., Finckh, A., Esdaile, J.M., De Pablo, P., Crofford, L., Costenbader, K., Chehab, G., Buyon, J., Bischoff-Ferrari, H., Benito-Garcia, E., Balow, J., Bombardieri, S., Alarcón, G.S., Abrahamowicz, M., Schneider, M., Fortin, P., Liang, M.H., Arthritis and Rheumatism, 2004, 10.1002/art.20628
  • Occupational and environmental exposures and risk of systemic lupus erythematosus: Silica, sunlight, solvents, Fortin, P.R., Rioux, J.D., Clarke, A., Claudio, J.O., Bernatsky, S., Wither, J., Cooper, G.S., Rheumatology, 2010, 10.1093/rheumatology/keq214
  • Autoantibodies in systemic lupus erythematosus: Comparison of historical and current assessment of seropositivity, Petri, M., Weisman, M., Stoll, T., Van Vollenhoven, R.F., Steinsson, K., Dooley, M.A., Kalunian, K., Buyon, J., Magder, L.S., Zoma, A., Isenberg, D., Aranow, C., Bruce, I., Sanchez-Guerrero, J., Sturfelt, G., Nived, O., Hanly, J.G., Ginzler, E., Merrill, J.T., Bae, S.-C., Manzi, S., Bernatsky, S., Clarke, A., Maddison, P., Ramsey-Goldman, R., Alarcón, G.S., Gordon, C., Costner, M., Werth, V., Urowitz, M., Fortin, P.R., Gladman, D., Wallace, D.J., Ippolito, A., Lupus, 2011, 10.1177/0961203310385738
  • Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations, Boilard, E., Fortin, P.R., Rauch, J., Dieudé, M., Hébert, M.-J., Belleannée, C., Tremblay, M.-È., Hajj, H.E., Pelletier, M., Wagner, É., Eder, L., Melki, I., Cloutier, N., Benk-Fortin, H., Rollet-Labelle, E., Lévesque, T., Allaeys, I., Marcoux, G., Julien, A.-S., Loignon, R.-C., Becker, Y., Scientific Reports, 2019, 10.1038/s41598-019-40900-3
  • International consensus for a definition of disease flare in lupus, Merrill, J.T., Werth, V.P., Von Feldt, J.M., Urowitz, M., Strand, V., Sontheimer, R.D., Sánchez-Guerrero, J., Sammaritano, L., Petri, M., Kalunian, K.C., Isenberg, D.A., Hahn, B., Grossman, J., Gordon, C., Ginzler, E., Gilkeson, G., Franks, A.G., Fortin, P.R., Fiorentino, D., Filocamo, G., Dooley, M.A., Cronin, M.E., Costner, M.I., Buyon, J.P., Brunetta, P., Brey, R.L., Belmont, H.M., Alarcón, G.S., Hanrahan, L.M., Ruperto, N., Lupus, 2011, 10.1177/0961203310388445
  • Increased expression of B cell activation factor supports the abnormal expansion of transitional B Cells in systemic lupus erythematosus, Wither, J., Fortin, P.R., Urowitz, M.B., Gladman, D.D., Scholey, J., Herzenberg, A., Reich, H., Wither, R., Landolt-Marticorena, C., Journal of Rheumatology, 2011, 10.3899/jrheum.100214
  • Lymphoma risk in systemic lupus: Effects of disease activity versus treatment, Clarke, A.E., Pierre, Y.St., Patel, N.M., Dreyer, L., Feldman, C.H., Blanco, I., Sturfelt, G.K., Criswell, L.A., Barr, S.G., Witte, T., Askanase, A., Romero-Diaz, J., Kamen, D.L., Aranow, C., Edworthy, S.M., Dooley, M.A., Peschken, C.A., Wallace, D.J., Bae, S.-C., Yelin, E., Ruiz-Irastorza, G., Gordon, C., Rahman, A., Isenberg, D., Ginzler, E.M., Manzi, S., Jacobsen, S., Petri, M.A., Nived, O., Fortin, P.R., Gladman, D.D., Urowitz, M.B., Costenbader, K.H., Boivin, J.-F., Joseph, L., Ramsey-Goldman, R., Bernatsky, S., Annals of the Rheumatic Diseases, 2014, 10.1136/annrheumdis-2012-202099
  • Evaluation of clinical outcomes and renal vascular pathology among patients with lupus, Fortin, P.R., Reich, H., Gladman, D., Urowitz, M., Wither, J., Scholey, J.W., Thomas, D., Nasr, S.H., Yip, J., Qian, G., Lou, W., Su, J., Aghdassi, E., Herzenberg, A., Barber, C., Clinical Journal of the American Society of Nephrology, 2012, 10.2215/CJN.02870311
  • Validation of the social interaction anxiety scale in scleroderma: A scleroderma patientcentered intervention network cohort study, Persmann, J., Pepin, M.R., Levis, B., Fedoruk, C., Delisle, V.C., Wilcox, P., Varga, J., Thorne, C., Sutton, E., Steen, V., Spiera, R., Smith, D., Roux, S., Robinson, D., Masetto, A., Manning, J., Liang, P., Korman, B., Khalidi, N., Kafaja, S., Fernandes, A.J.D.B., Jones, N., Ikic, A., Hinchcliff, M., Herrick, A.L., Gyger, G., Gordon, J., Gill, A., Fortin, P., Dunne, J.V., Domsic, R., Denton, C., Dagenais, P., Chung, L., Carreira, P., Bruns, A., Boire, G., Bissonnette, L., Arsenault, G., Albert, A., Wong-Rieger, D., Welling, J., Suarez-Almazor, M.E., Steele, R.J., Schouffoer, A.A., Reyna, T.S.R., Portales, A., Pope, J., Nielsen, K., Marra, C., Leite, C., Larche, M., Kennedy, A.T., Johnson, S.R., Jang, Y., Impens, A., Harel, D., Hudson, M., Godard, D., Frech, T., Fortune, C., Fligelstone, K., Van Den Ende, C., Ells, C., El-Baalbaki, G., Maia, A.C., Boutron, I., Assassi, S., Wigley, F., Sauve, M., Riggs, R., Poiraudeau, S., Nielson, W.R., Mouthon, L., Mayes, M.D., Van Den Hoogen, F., Furst, D., Bartlett, S.J., Baron, M., Malcarne, V.L., Thombs, B.D., Roesch, S., Gottesman, K., Jewett, L.R., Fox, R.S., Mills, S.D., Carrier, M.-E., Kwakkenbos, L., Gholizadeh, S., Journal of Scleroderma and Related Disorders, 2018, 10.5301/jsrd.5000264
  • Factors associated with damage accrual in patients with systemic lupus erythematosus: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort, Urowitz, M.B., Inanc, M., Peschken, C.A., Kamen, D.L., Lim, S., Ruiz-Irastorza, G., Kalunian, K.C., Van Vollenhoven, R.F., Ramos-Casals, M., Mackay, M., Aranow, C., Nived, O., Sturfelt, G.K., Zoma, A.A., Ramsey-Goldman, R., Khamashta, M.A., Dooley, M.A., Steinsson, K., Petri, M., Fortin, P.R., Fessler, B.J., Alarcón, G.S., Merrill, J.T., Rahman, A., Isenberg, D.A., Ginzler, E.M., Bernatsky, S., Clarke, A.E., Wallace, D.J., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Bae, S.-C., Gladman, D.D., Su, L., Manzi, S., Hanly, J.G., Farewell, V., O'Keeffe, A.G., Bruce, I.N., Annals of the Rheumatic Diseases, 2015, 10.1136/annrheumdis-2013-205171
  • What have multicentre registries across the world taught us about the disease features of systemic sclerosis?, Ng, S.C., Lim, A.Y.N., Chan, G., Teng, G., Low, A.H.L., Cosentino, V., Montoya, F., Kerzberg, E., Karpec, D., Rugiene, R., Venalis, P., Butrimiene, I., Venalis, A., Litinsky, I., Chifflot, H., Gottenberg, J.E., Chatelus, E., Sibilia, J., Exposito, M.V., Rubio, S.R., García de la Peña Lefebvre, P., Kafaja, S., Furst, D.E., Ancuta, C., Chirieac, R., Tiglea, I., Dumitrascu, A., Popescu, M., Tanaseanu, C.-M., Pisarri, S., Rosato, E., Loyo, E., O’Rourke, M., Veale, D., Doube, A., Solanki, K., O’Donnell, J., Chapman, P., Stamp, L., Highton, J., Stebbings, S., Zenone, T., Russu, E., Chiaburu, L., Groppa, L., Agachi, S., Azevedo, V.F., de Souza Müller, C., Radominski, S.C., Mayer, M., Baresic, M., Anic, B., Günther, C., Aringer, M., Saar, P., Krummel-Lorenz, B., Morgiel, E., Sokolik, R., Szmyrka-Kaczmarek, M., Wiland, P., Szechinski, J., Knott, E., Hein, R., Eyerich, K., Pozzi, M.R., Iversen, L., Ullman, S., Corrado, A., Cantatore, F.P., Smith, V., De Keyser, F., Mouthon, L., Zeni, S., Meroni, P., Distler, J.H., Schett, G., Bojinca, M., Dobrota, R., Gorga, M., Gherghe, A.M., Ionitescu, R., Cornateanu, R.S., Mihai, C.M., Wigley, F.M., Groseanu, L., Opris, D., Ionescu, R.M., Riccieri, V., Valesini, G., Launay, D., Garen, T., Midtvedt, Ø., Giraldo, W.A.S., de la Puente Buijdos, C., Mendoza, A.Z., Szücs, G., Damgaard, K., Nielsen, H., Strauss, G., Engelhart, M., Starovoytova, M.N., Tikly, M., Stankovic, A., Stamenkovic, B., Salvador, M.J., Himsel, A., Oleszowsky, M., Burkhardt, H., Seidel, M., Krasowska, D., Heitmann, S., Santamaria, V.O., Henes, J., Denton, C., Black, C., Caramaschi, P., Bambara, L.M., Pellerito, R., Hunzelmann, N., Lo Monaco, A., Govoni, M., Martinovic, D., Wollheim, F., Scheja, A., Hesselstrand, R., Hij, A., Farge, D., Gabrielli, A., Coleiro, B., Mallia, C., Rozman, B., Widuchowska, M., Kopec-Medrek, M., Kotulska, A., Kucharz, E.J., Chizzolini, C., Varju, C., Czirják, L., Novak, S., Caporali, R., Montecucco, C., Vlachoyiannopoulos, P., Nicoara, I., Rednic, S., Vettori, S., Cuomo, G., Sulli, A., Cutolo, M., Sierakowsky, S., Becvar, R., Iannone, F., Lapadula, G., Tyndall, A., Maurer, B., Müller-Ladner, U., Li, M., Busquets, J., Jimenez, S., Scorza, R., Ananieva, L.P., Damjanov, N., Braun-Moscovici, Y., Gurman, A.B., Cozzi, F., Carreira, P.E., Valentini, G., Hachulla, E., Air, P., Riemekasten, G., Guiducci, S., Walker, U.A., Avouac, J., Fritzler, M., Cabral, A.R., Rodriguez-Reyna, T.S., Abu-Hakima, M., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., LeClercq, S., Grodzicky, T., Ligier, S., Hudson, M., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Pope, J., Zochling, J., Walker, J., Thakkar, V., Strickland, G., Roddy, J., Rischmueller, M., Proudman, S., Ngian, G.-S., Nash, P., Lester, S., Hill, C., Nikpour, M., Santosa, A., Law, W.G., Teng, G.G., H.L. Low, A., Matucci-Cerinic, M., Kowal-Bielecka, O., Distler, O., Allanore, Y., Pope, J., Hudson, M., Baron, M., Sahhar, J., Wilson, M.E., Stevens, W., Huq, M., Proudman, S.M., Journal of Scleroderma and Related Disorders, 2017, 10.5301/jsrd.5000256
  • Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome, Fortin, P.R., Boilard, É., Godbout, A., Julien, A.-S., Becker, Y.L.C., Lupus, 2020, 10.1177/0961203320944481
  • Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS), Fritzler, M.J., Fortin, P.R., Ikic, A., Thorne, C., Smith, D., Maltez, N., Rodriguez-Reyna, T.S., Robinson, D., Sutton, E., Masetto, A., Khalidi, N.A., Larché, M.J., Gyger, G., Hudson, M., Baron, M., Pope, J.E., Baron, M., Wang, M., Hudson, M., Zheng, B., Arthritis Research and Therapy, 2020, 10.1186/s13075-020-02220-0
  • Prognostic factors in systemic necrotizing vasculitis of the polyarteritis nodosa group - A review of 45 cases, Esdaile, J.M., Choquette, D., Yeadon, C.A., Watters, A.K., Larson, M.G., Fortin, P.R., Journal of Rheumatology, 1995
  • Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis, Fortin, P.R., Lepage, K., Neville, C., Newkirk, M.M., Lucey, M.D., Journal of Rheumatology, 2000
  • Determinants of health status in fibromyalgia: A comparative study with systemic lupus erythematosus, Clarke, A.E., Choquette, D., Rich, E., Goulet, J.R., Senécal, J.-L., Zummer, M., Beaulieu, A., Fortin, P.R., Fitzcharles, M.-A., Da Costa, D., Dobkin, P.L., Journal of Rheumatology, 2000
  • Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry, Erkan, D., Wahl, D., Vega, J., Bertolaccini, M.L., Willis, R., Atsumi, T., Knight, J.S., Cervera, R., Rodriguez, E., Petri, M., Nalli, C., Jesus, G.R.D., Branch, D.W., Cohen, H., Efthymiou, M., Ji, L., Fortin, P., Zamorano, M.A.A., Michael Belmont, H., Gerosa, M., Ugarte, A., Tektonidou, M.G., Pengo, V., Sciascia, S., Andrade, D., Bauman, C., Clerc-Urmès, I., Zuily, S., Lupus, 2020, 10.1177/0961203320940776
  • Erratum: Incorrect values for intractable and cluster headaches at enrollment shown in figure 1 and incorrect prevalence of headache at ten years in text of the article by hanly et al (Arthritis and Rheumatology (2013)), Farewell, V., Thompson, K., Theriault, C., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Lim, S.S., Kalunian, K.C., Ruiz-Irastorza, G., Mackay, M., Aranow, C., Ramos-Casals, M., Van Vollenhoven, R.F., Zoma, A.A., Nived, O., Sturfelt, G.K., Manzi, S., Ramsey-Goldman, R., Khamashta, M.A., Steinsson, K., Dooley, M.A., Bruce, I.N., Alarcõn, G.S., Fessler, B.J., Gladman, D.D., Fortin, P.R., Petri, M., Merrill, J.T., Rahman, A., Isenberg, D.A., Ginzler, E.M., Wallace, D.J., Bernatsky, S., Clarke, A.E., Romero-Diaz, J., Sanchez-Guerrero, J., Bae, S.-C., Gordon, C., O'Keeffe, A.G., Urowitz, M.B., Hanly, J.G., Arthritis and Rheumatology, 2014, 10.1002/art.38707
  • Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus, Fortin, P.R., Gladman, D., Urowitz, M., Greenwood, C., Lim, S., Tisseverasinghe, A., Arthritis and Rheumatism, 2006, 10.1002/art.21929
  • A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus Cohort, Pope, J.E., Peschken, C., Chedeville, G., Huber, A.M., Fortin, P., Hudson, M., Zummer, M., Arbillaga, H., Petty, R., Tucker, L., Smith, C.D., Pineau, C., Bernatsky, S., Hitchon, C., Silverman, E.D., Levy, D.M., Kim, H., Rheumatology (United Kingdom), 2019, 10.1093/rheumatology/kez006
  • A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis, Puechal, X., Ludivico, C., Segal, A.M., Gross, W., Choi, H.K., Soubrier, M., Ferland, D., Walsh, B., Baca, S., Sherrer, Y., McRorie, E., Nuki, G., Luqmani, R.A., Prayson, R., Kosmorsky, G., Fessler, B.J., Mandell, B.F., Scheetz, R.J., Wilke, W.S., Klashman, D., Kalunian, K., Hoffman, D.B., Bork, D., Lopez-Soto, A., Hernández-Rodríguez, J., Swanson, H., Tuggle, C., Sneller, M.C., Hunder, G.G., Schned, E., Easley, K.A., Locker, G.A., Flynn, J.A., Fortin, P., Merkel, P.A., Dickler, H., Calabrese, L.H., Cohen, P., Schousboe, J., Stone, J.H., Guillevin, L., Hellmann, D.B., Cid, M.C., Hoffman, G.S., Arthritis and Rheumatism, 2002, 10.1002/art.10262
  • The needs of patients with arthritis: The patient's perspective, Esdaile, J.M., Du Berger, R., Abrahamowitz, M., Baron, M., Fitzcharles, M.-A., Fortin, P.R., Neville, C., Arthritis Care and Research, 1999, 10.1002/1529-0131(199904)12:2<85::aid-art3>3.0.co;2-w
  • Clinical correlates of faecal incontinence in systemic sclerosis: Identifying therapeutic avenues, Fritzler, M., Cabral, A.R., Rodriguez-Reyna, T.S., Abu-Hakima, M., Fortin, P.R., Smith, D., Thorne, C., Sutton, E., Masetto, A., LeClercq, S., Kaminska, E., Docherty, P., Jones, N., Robinson, D., Markland, J., Gyger, G., Grodzicky, T., Ligier, S., Mathieu, J.-P., Pope, J., Masetto, A., Thorne, C., Fortin, P.R., Albert, A., Larché, M., Carrier, N., Pope, J.E., Khalidi, N., Sutton, E., Baron, M., Gyger, G., Hudson, M., Richard, N., Rheumatology (United Kingdom), 2017, 10.1093/rheumatology/kew441
  • Association of autoantibodies to heat-shock protein 60 with arterial vascular events in patients with antiphospholipid antibodies, Rauch, J., Fortin, P.R., Solymoss, S., Kassis, J., Su, J., Landolt-Marticorena, C., Subang, R., Levine, J.S., Pineau, C., Neville, C., Correa, J.A., Dieudé, M., Arthritis and Rheumatism, 2011, 10.1002/art.30411
  • Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus, Busque, L., Silverman, E., Perreault, C., Bolduc, V., Gingras, M., Belisle, C., Provost, S., Fortin, P.R., Hébert, J., Schneider, R., Chagnon, P., Arthritis and Rheumatism, 2006, 10.1002/art.21733
  • Thrombovascular events affect quality of life in patients with systemic lupus erythematosus, Fortin, P.R., Urowitz, M.B., Gladman, D.D., Yeo, E., Aghdassi, E., Su, J., Peeva, V., Balitsky, A.K., Journal of Rheumatology, 2011, 10.3899/jrheum.101054
  • Costs of rheumatoid arthritis: New estimates from the human capital method and comparison to the willingness-to-pay method, Penrod, J.R., Donaldson, C., Menard, H.A., Fortin, P.R., Panaritis, T., St-Pierre, Y., Adam, V., Guillemin, F., Clarke, A.E., Fautrel, B., Medical Decision Making, 2007, 10.1177/0272989X06297389
  • Longitudinal evolution of risk of coronary heart disease in systemic lupus erythematosus, Esdaile, J.M., Pineau, C.A., Neville, C., Pilote, L., Fortin, P.R., Abrahamowicz, M., Karp, I., Journal of Rheumatology, 2012, 10.3899/jrheum.111127
  • Antiphospholipid antibodies predict imminent vascular events independently from other risk factors in a prospective cohort, Fortin, P.R., Levine, J.S., Belisle, P., Joseph, L., Solymoss, S., Kassis, J., Rauch, J., Neville, C., Thrombosis and Haemostasis, 2009, 10.1160/TH08-06-0384
  • Common variants in the NLRP3 region contribute to Crohn's disease susceptibility, Franchimont, D., Hudson, T.J., Vermeire, S., Rioux, J.D., Rutgeerts, P., Sarfati, M., Wither, J.E., Fortin, P.R., Langelier, D., Cohen, A., Gaudet, D., Bitton, A., Belaiche, J., Libioulle, C., Baba, N., Collette, C., Silverberg, M.S., Louis, E., Fortin, G., Lemire, M., Villani, A.-C., Nature Genetics, 2009, 10.1038/ng.285
  • A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach, Farewell, V., Theriault, C., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., van Vollenhoven, R.F., Zoma, A.A., Sturfelt, G.K., Nived, O., Manzi, S., Fessler, B.J., Alarcón, G.S., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Sanchez-Guerrero, J., Gladman, D.D., Fortin, P., Dooley, M.A., Bruce, I.N., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Merrill, J.T., Wallace, D.J., Clarke, A.E., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., Urowitz, M.B., Su, L., Hanly, J.G., Arthritis and Rheumatology, 2016, 10.1002/art.39674
  • Systemic autoimmune rheumatic disease prevalence in Canada: Updated analyses across 7 provinces, Bernatsky, S., Bergeron, L., Badley, E.M., Bélisle, P., Smith, M., Clarke, A.E., Pineau, C.A., Svenson, L., Edworthy, S.M., Peschken, C., Jean, S., Hudson, M., Fortin, P.R., Barnabe, C., O'Donnell, S., Lix, L., Hanly, J.G., Joseph, L., Lacaille, D., Aviña-Zubieta, J.A., Broten, L., Journal of Rheumatology, 2014, 10.3899/jrheum.130667
  • A subset of rheumatoid factors crossreacts with cardiolipin in patients positive for IgM rheumatoid factor and anticardiolipin antibodies [4], Rauch, J., Newkirk, M.M., Subang, R., Fortin, P.R., Galperin, I., Journal of Rheumatology, 2000
  • Persistent disease activity remains a burden for patients with systemic lupus erythematosus, Fortin, P.R., Wynant, W., Chédeville, G., Arbillaga, H., Avina-Zubieta, A., Smith, C.D., Huber, A.M., Hitchon, C.A., Hudson, M., Levy, D., Pineau, C., Tucker, L., Zummer, M., Ross, J., Iczkovitz, S., Sayani, A., Silverman, E., Pope, J., Abrahamowicz, M., Wang, Y., Peschken, C.A., Journal of Rheumatology, 2019, 10.3899/jrheum.171454
  • Osteopontin and disease activity in patients with recent-onset systemic Lupus Erythematosus: Results from the SLICC Inception Cohort, Sjöwall, C., Wetterö, J., Bruce, I.N., Stoll, T., Askanase, A., Peschken, C., Jacobsen, S., Kamen, D.L., Ramos-Casals, M., Van Vollenhoven, R., Inanc, M., Kalunian, K., Lim, S., Ruiz-Irastorza, G., Zoma, A., Steinsson, K., Nived, O., Ramsey-Goldman, R., Manzi, S., Dooley, M.A., MacKay, M., Aranow, C., Khamashta, M., Petri, M., Chatham, W.W., Alarcón, G.S., Ginzler, E., Merrill, J., Rahman, A., Isenberg, D.A., Gordon, C., Wallace, D., Hanly, J.G., Bernatsky, S., Clarke, A.E., Sanchez-Guerrero, J., Fortin, P.R., Bae, S.-C., Romero-DIaz, J., Gladman, D.D., Urowitz, M.B., Jönsen, A., Padyukov, L., Skogh, T., Enocsson, H., Wirestam, L., Journal of Rheumatology, 2019, 10.3899/jrheum.180713
  • Lack of association between the interferon-α signature and longitudinal changes in disease activity in systemic lupus erythematosus, Wither, J., Fortin, P.R., Urowitz, M., Gladman, D.D., Su, J., Unnithan, T., Ferguson, C., Lubovich, A., Bonventi, G., Landolt-Marticorena, C., Annals of the Rheumatic Diseases, 2009, 10.1136/ard.2008.093146
  • Interstitial lung disease is associated with an increased risk of lung cancer in systemic sclerosis: Longitudinal data from the Canadian Scleroderma Research Group, Fritzler, M., Cabral, A.R., Rodriguez-Reyna, T.S., Abu-Hakima, M., Fortin, P.R., Larché, M., Smith, D., Gyger, G., Thorne, C., Leclercq, S., Grodzicky, T., Ligier, S., Hudson, M., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Pope, J., Bernatsky, S., Baron, M., Younanian, E., Wang, M., Hudson, M., Sakr, L., Journal of Scleroderma and Related Disorders, 2018, 10.1177/2397198318766825
  • The comparability of functional assessment of chronic illness therapy - Fatigue scores between cancer and systemic sclerosis, Fritzler, M., Fortin, P.R., Thorne, C., Smith, D., Rodriguez-Reyna, T.S., Robinson, D., Sutton, E., Masetto, A., Khalidi, N., Larché, M., Pope, J., Gyger, G., Thombs, B.D., Cella, D., Baron, M., Hudson, M., Levis, B., Kwakkenbos, L., Coroiu, A., Journal of Scleroderma and Related Disorders, 2017, 10.5301/jsrd.5000227
  • Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies, Fortin, P.R., Le Comte, M., Joseph, L., Chang, E.R., Kassis, J., Rauch, J., Neville, C., Thrombosis and Haemostasis, 2003, 10.1055/s-0037-1613606
  • Effect of delay in initiating radiotherapy for patients with early stage breast cancer, Freeman, C.R., Ho, V., Levinton, C., Belisle, P., Zhang, G., Fortin, P., Joseph, L., Benk, V., Clinical Oncology, 2004, 10.1016/j.clon.2003.10.008
  • The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort, Andrade, D., Bertolaccini, M.L., Mackie, I., Efthymiou, M., Barbhaiya, M., Sevim, E., Banzato, A., Borges Gualhardo Vendramini, M., Rossi Gandara, A.P., Lopez-Pedrera, R., Gonzalez, E., Willis, R., Atsumi, T., Knight, J.S., Rodriguez-Pinto, I., Rodriguez, E., Petri, M., Andreoli, L., Fortin, P.R., Branch, D.W., Ramires de Jesús, G., Cohen, H., Belmont, H.M., Ji, L., Meroni, P., Ugarte, A., Tektonidou, M.G., Pengo, V., Erkan, D., Sciascia, S., Radin, M., Seminars in Arthritis and Rheumatism, 2019, 10.1016/j.semarthrit.2019.04.009
  • Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach, Clarke, A.E., Buyon, J., Stoll, T., Farewell, V., Askanase, A., Jacobsen, S., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S.S., Ruiz-Irastorza, G., Ramos-Casals, M., van Vollenhoven, R.F., Zoma, A.A., Jönsen, A., Nived, O., Manzi, S., Alarcón, G.S., Mackay, M., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Sanchez-Guerrero, J., Gladman, D.D., Fortin, P.R., Dooley, M.A., Bruce, I.N., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Merrill, J.T., Wallace, D.J., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., St. Pierre, Y., Urowitz, M.B., Su, L., Hanly, J.G., Barber, M.R.W., Arthritis Care and Research, 2020, 10.1002/acr.24092
  • Purpura fulminans and anticardiolipin antibodies in a patient with Grave's disease, Fortin, P.R., Kassis, J., Watters, A.K., Pham, C.D., Ligier, S., Scandinavian Journal of Rheumatology, 2002, 10.1080/030097402320817112
  • The systemic lupus erythematosus tri-nation study: Cumulative indirect costs, Clarke, A.E., Esdaile, J.M., Grodzicky, T., Choquette, D., Goulet, J.-R., Sutcliffe, N., Fortin, P.R., Pineau, C., St. Pierre, Y., Joseph, L., Penrod, J.R., Senégal, J.-L., Gordon, C., Isenberg, D.A., Manzi, S., Petri, M., Panopalis, P., Arthritis Care and Research, 2007, 10.1002/art.22470
  • Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen, Vinet, E., Costedoat-Chalumeau, N., Bruce, I.N., Askanase, A., Sanchez-Guerrero, J., Jacobsen, Sø., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S., Ruiz-Irastorza, G., Ramos-Casals, M., Van Vollenhoven, R.F., Zoma, A.A., Jönsen, A., Nived, O., Manzi, S., Alarcón, G., MacKay, M., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Gladman, D.D., Fortin, P., Dooley, M.A., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Buyon, J., Merrill, J.T., Wallace, D.J., Bae, S.-C., Gordon, C., Romero-Diaz, J., Clarke, A.E., Urowitz, M.B., Hanly, J.G., St-Pierre, Y., Pineau, C.A., Bernatsky, S., Mendel, A., Rheumatology (United Kingdom), 2019, 10.1093/rheumatology/kez014
  • Chest radiographs as a screening test for diffuse idiopathic skeletal hyperostosis, Esdaile, J.M., Fortin, P.R., Shiroky, J.B., Fitzcharles, M.-A., Watts, C.S., Dussault, R., Kaplan, P., Joseph, L., Hill, R.O., Mata, S., Journal of Rheumatology, 1993
  • Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study, Farewell, V., Theriault, C., Askanase, A., Kamen, D.L., Peschken, C.A., Jacobsen, S., Kalunian, K.C., Inanc, M., Lim, S.S., Ramos-Casals, M., Ruiz-Irastorza, G., Mackay, M., Aranow, C., van Vollenhoven, R.F., Alarcón, G.S., Khamashta, M.A., Jonsen, A., Nived, O., Manzi, S., Zoma, A.A., Ramsey-Goldman, R., Steinsson, K., Dooley, M.A., Ginzler, E., Petri, M., Bruce, I.N., Gladman, D.D., Fortin, P.R., Merrill, J.T., Rahman, A., Isenberg, D.A., Wallace, D.J., Clarke, A.E., Bernatsky, S., Sanchez-Guerrero, J., Romero-Diaz, J., Bae, S.-C., Gordon, C., Urowitz, M.B., Su, L., Li, Q., Hanly, J.G., Arthritis and Rheumatology, 2019, 10.1002/art.40764
  • Health-related quality of life (HRQoL) in idiopathic inflammatory myopathy: A systematic review, Fritzler, M., Fortin, P.R., Gyger, G., Vinet, E., O'Ferrall, E., Genge, A., Baron, M., Hudson, M., Wojcik, S., Regardt, M., Leclair, V., PLoS ONE, 2016, 10.1371/journal.pone.0160753
  • Lung cancer in systemic lupus erythematosus, Clarke, A.E., Ramsey-Goldman, R., Sturfeldt, G., Nived, O., Petri, M., Rahman, A., Isenberg, D., Manzi, S., Urowitz, M., Fortin, P.R., Gladman, D., Ginzler, E., Boivin, J.-F., Gordon, C., Bernatsky, S., Bin, J., Lung Cancer, 2007, 10.1016/j.lungcan.2007.01.007
  • Determinants of discordance between patients and physicians in their assessment of lupus disease activity, Fortin, P.R., Battista, R.N., Clarke, A.E., Dobkin, P.L., Abrahamowicz, M., Yen, J.C., Journal of Rheumatology, 2003
  • Examination of the association of sex and race/ethnicity with appearance concerns: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study, Persmann, J., Pepin, M.R., Milette, K., Levis, B., Fedoruk, C., Delisle, V.C., Wilcox, P., Varga, J., Thorne, C., Sutton, E., Spiera, R., Smith, D., Schiopu, E., Roux, S., Robinson, D., Masetto, A., Liang, P., Korman, B., Khalidi, N., Kafaja, S., Fernandes, A.J.B., Jones, N., Ikic, A., Hinchcliff, M., Manning, J., Herrick, A.L., Gyger, G., Gordon, J., Gill, A., Fortin, P., Dunne, J.V., Domsic, R., Denton, C.P., Dagenais, P., Chung, L., Carreira, P., Bruns, A., Boire, G., Bissonnette, L., Arsenault, G., Albert, A., Wong-Rieger, D., Welling, J., Suarez-Almazor, M.E., Steele, R.J., Schouffoer, A.A., Reyna, T.S.R., Portales, A., Pope, J., Poole, J.L., Nielsen, K., Marra, C., Leite, C., Larche, M., Kennedy, A.T., Jang, Y., Impens, A., Hudson, M., Harel, D., Godard, D., Frech, T., Fortune, C., Fligelstone, K., van den Ende, C., Ells, C., El-Baalbaki, G., Maia, A.C., Boutron, I., Wigley, F., Sauve, M., Riggs, R., Poiraudeau, S., Nielson, W.R., Mouthon, L., Khanna, D., van den Hoogen, F., Baron, M., Thombs, B.D., Rice, D.B., Molnar, J.C., Mills, S.D., Gholizadeh, S., Fox, R.S., Steen, V., Körner, A., Johnson, S.R., Williamson, H., Harcourt, D., Assassi, S., Mayes, M.D., Gottesman, K., Furst, D.E., Bartlett, S.J., Malcarne, V.L., Carrier, M.-E., Kwakkenbos, L., Jewett, L.R., Clinical and Experimental Rheumatology, 2016
  • IgG-aggregates rapidly upregulate FcgRI expression at the surface of human neutrophils in a FcgRII-dependent fashion: A crucial role for FcgRI in the generation of reactive oxygen species, Pouliot, M., Boilard, E., Fortin, P.R., Laflamme, C., Huot, S., FASEB Journal, 2020, 10.1096/fj.202001085R
  • Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study, Mills, S.D., Pepin, M.R., Milette, K., Levis, B., Jewett, L.R., Fedoruk, C., Gholizadeh, S., Fox, R.S., Delisle, V.C., Wilcox, P., Varga, J., Thorne, C., Steen, V., Spiera, R., Smith, D., Schiopu, E., Roux, S., Robinson, D., Masetto, A., Liang, P., Larche, M., Korman, B., Khalidi, N., Kafaja, S., Fernandes, A.J.D.B., Jones, N., Hinchcliff, M., Herrick, A., Gyger, G., Gordon, J., Fortin, P., Dunne, J.V., Domsic, R., Denton, C., Dagenais, P., Chung, L., Carreira, P., Arsenault, G., Albert, A., Wong-Rieger, D., Welling, J., Steele, R.J., Schouffoer, A.A., Sofia Rodriguez Reyna, T., Portales, A., Poole, J.L., Marra, C., Leite, C., Körner, A., Tyrell Kennedy, A., Johnson, S.R., Jang, Y., Impens, A., Harel, D., Godard, D., Fortune, C., Fligelstone, K., van den Ende, C.H.M., Ells, C., El-Baalbaki, G., Costa Maia, A., Boutron, I., Assassi, S., van den Hoogen, F., Riggs, R., Mayes, M.D., Gottesman, K., Furst, D., Thombs, B.D., Wigley, F.M., Suarez-Almazor, M.E., Sauve, M., Pope, J., Hudson, M., Frech, T., Baron, M., Nielsen, K., Poiraudeau, S., Nielson, W.R., Mouthon, L., Malcarne, V.L., Bartlett, S.J., Carrier, M.-E., Kwakkenbos, L., Riehm, K.E., Arthritis Care and Research, 2016, 10.1002/acr.22807
  • Mammalian target of rapamycin is activated in the kidneys of patients with scleroderma renal crisis, Fritzler, M., Fortin, P.R., Thorne, C., Smith, D., Rodriguez-Reyna, T.S., Robinson, D., Sutton, E., Masetto, A., Khalidi, N., Larché, M., Pope, J., Gyger, G., Hudson, M., Baron, M., Hudson, M., Baron, M., Berkson, L., Del Rincon, S., Fiset, P., Takano, T., Patey, N., Salituri, J., Journal of Scleroderma and Related Disorders, 2019, 10.1177/2397198319885488
  • Measuring the Impact of MyLupusGuide in Canada: Results of a Randomized Controlled Study, Deborah Da Costa, Murray Rochon, J. Antonio Avina‐Zubieta, Stephanie Keeling, Ann E. Clarke, Janet E. Pope, Mark Matsos, Doug Smith, Marie Hudson, Evelyne Vinet, Christine A. Peschken, Davy Eng, Anna‐Lisa Morrison, Jodie Nimigon‐Young, Vinita Haroun, Elham Rahme, Anne‐Sophie Julien, Carolyn Neville, Paul R. Fortin, Arthritis Care & Research, 2023, 10.1002/acr.24871
  • Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory Diseases, Gilaad G. Kaplan, Dawn P. Richards, Laurie Proulx, Nick Bansback, Mark Harrison, Claire E.H. Barber, Megan Thomas, Todd Wilson, Dianne Mosher, Ann E. Clarke, Sasha Bernatsky, Paul R. Fortin, Carol Hitchon, Ines Colmegna, Glen S. Hazlewood, The Journal of Rheumatology, 2023, 10.3899/jrheum.220697
  • The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for systemic lupus erythematosus international comparison, Sturfelt, G., Snaith, M., Nived, O., Petri, M., Isenberg, D.A., Hanly, J.G., Gordon, C., Ginzler, E., Fortin, P., Bacon, P., Urowitz, M.B., Goldsmith, C.H., Gladman, D.D., Journal of Rheumatology, 2000
  • Race/ethnicity and cancer occurrence in systemic lupus erythematosus, Ramsey-Goldman, R., Clarke, A., St. Pierre, Y., McCarthy, T., El-Gabalawy, H., Rajan, R., Ensworth, S., Pope, J., Nived, O., Sturfelt, G., Hanly, J., Alarcon, G.S., Dooley, M.A., Aranow, C., Steinsson, K., Rahman, A., Isenberg, D., Sibley, J., Petri, M., Bae, S.C., Edworthy, S., Barr, S., Gordon, C., Fortin, P., Gladman, D., Urowitz, M., Ginzler, E., Manzi, S., Joseph, L., Boivin, J.F., Bernatsky, S., Arthritis Care and Research, 2005, 10.1002/art.21458
  • Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee, Katz, J.N., Fossel, A.H., Sledge, C., Tanzer, M., Mahomed, N., Phillips, C.B., Ferland, D., Liang, M.H., Bélisle, P., Joseph, L., St-Pierre, Y., Clarke, A.E., Penrod, J.R., Fortin, P.R., Arthritis and Rheumatism, 2002, 10.1002/art.10631
  • A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis, Wither, J., Boutros, P.C., Fortin, P.R., Avila-Casado, C., Scholey, J., Reich, H., Bonilla, D., Noamani, B., Morrison, S., Prokopec, S.D., Landolt-Marticorena, C., Arthritis Research and Therapy, 2016, 10.1186/s13075-016-1120-0
  • Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort, Peschken, C., Tucker, L., Hudson, M., Zummer, M., Urowitz, M., Gladman, D., Arbillaga, H., Smith, C.D., Pineau, C., Fortin, P.R., Silverman, E., Pope, J.E., Borowoy, A.M., Seminars in Arthritis and Rheumatism, 2012, 10.1016/j.semarthrit.2012.03.011
  • The relationship between health status, social support and satisfaction with medical care among patients with systemic lupus erythematosus, Danoff, D.S., Esdaile, J.M., Fortin, P.R., Senecal, J.-L., Dobkin, P.L., Clarke, A.E., Da Costa, D., International Journal for Quality in Health Care, 1999, 10.1093/intqhc/11.3.201
  • Role of radiation therapy in patients with a diagnosis of both systemic lupus erythematosus and cancer, Fortin, P.R., Urowitz, M., Gladman, D., Al-Herz, A., Benk, V., Arthritis Care and Research, 2005, 10.1002/art.20912
  • Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study, Rahman, A., Zoma, A., Wallace, D.J., van Vollenhoven, R., Sturfelt, G.K., Steinson, K., Sanchez-Guerrero, J., Ruiz-Irastorza, G., Ramsey-Goldman, R., Petri, M., Peschken, C., Nived, O., Merrill, J., Manzi, S., Lim, S., Khamashta, M., Kamen, D., Kalunian, K., Jacobsen, S., Inanc, M., Gordon, C., Gladman, D., Ginzler, E., Fortin, P., Dooley, M.A., Clarke, A.E., Buyon, J., Bruce, I.N., Bernatsky, S., Bae, S.-C., Askanase, A., Aranow, C., Anderson, N., Urowitz, M.B., Hanly, J.G., Ioannou, Y., Isenberg, D., Giles, I., Miller, S., Matharu, M., Raimondo, M.G., Croca, S., Ferreira, I., Arthritis Research and Therapy, 2017, 10.1186/s13075-017-1495-6
  • The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus, Fortin, P.R., Urowitz, M.B., Gladman, D.D., Lou, W., Su, J., Akhavan, P.S., Journal of Rheumatology, 2013, 10.3899/jrheum.120572
  • Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus, Fortin, P.R., Pope, J., Pineau, C., DaCosta, D., Hewitt, S., Neville, C., Peeva, V., Cymet, A., Morrison, S., Cheung, A.M., Aghdassi, E., Lee, J.J.Y., Journal of Rheumatology, 2012, 10.3899/jrheum.111589
  • The non-haemostatic role of platelets in systemic lupus erythematosus, Boilard, E., Bengtsson, A.A., Lood, C., Fortin, P.R., Linge, P., Nature Reviews Rheumatology, 2018, 10.1038/nrrheum.2018.38
  • Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study, Hudson, M., Wang, M., Fritzler, M.J., Cabral-Castaneda, A.R., Rodriguez-Reyna, T.S., Abu-Hakima, M., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., LeClercq, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Pope, J., Baron, M., Rheumatology (United Kingdom), 2016, 10.1093/rheumatology/kew313
  • Peripheral Neuropathy in Patients with Systemic Lupus Erythematosus, Fortin, P.R., Urowitz, M.B., Gladman, D.D., Su, J., Aghdassi, E., Florica, B., Seminars in Arthritis and Rheumatism, 2011, 10.1016/j.semarthrit.2011.04.001
  • Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus, Wither, J.E., Urowitz, M.B., Gladman, D.D., Fortin, P.R., Landolt-Marticorena, C., Kim, J.J., Li, T.T., Chang, N.-H., Journal of Autoimmunity, 2015, 10.1016/j.jaut.2015.01.009
  • Smoking is the most significant modifiable lung cancer risk factor in systemic lupus erythematosus, Clarke, A.E., Pierre, Y.S., Hansen, J.E., Rahman, A., Isenberg, D., Bae, S.-C., Aranow, C., Nived, O., Gordon, C., Peschken, C., Hanly, J.G., Ginzler, E., Yelin, E.H., Fortin, P.R., Gladman, D.D., Urowitz, M.B., Petri, M., Ramsey-Goldman, R., Bernatsky, S., Journal of Rheumatology, 2018, 10.3899/jrheum.170652
  • Antiphospholipid antibodies and thrombosis: Association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis, Fortin, P.R., Subang, R., Le Comte, M., Joseph, L., Chang, E.R., Busque, L., Rauch, J., Neville, C., Kassis, J., Thrombosis and Haemostasis, 2004, 10.1160/TH04-03-0138
  • Thinking outside the box-The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect, Fritzler, M., Larché, M., Fortin, P.R., Smith, D., Gyger, G., Thorne, C., LeClercq, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Sutton, E., Masetto, A., Kaminska, E., Docherty, P., Khalidi, N., Jones, N., Robinson, D., Markland, J., Pope, J., Fritzler, M.J., Baron, M., Wang, M., Tatibouet, S., Hudson, M., Srivastava, N., Seminars in Arthritis and Rheumatism, 2015, 10.1016/j.semarthrit.2015.04.009
  • Designing an intervention for women with systemic lupus erythematosus from medically underserved areas to improve care: A qualitative study, Costenbader, K.H., Massarotti, E., Fortin, P.R., Todd, D.J., Fraser, P., Zibit, M., Bermas, B.L., Feldman, C.H., Lupus, 2013, 10.1177/0961203312463979
  • The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort, Pope, J.E., Fortin, P.R., Hitchon, C., Hudson, M., Bernatsky, S., Clarke, A., Zummer, M., Arbillaga, H., Smith, C.D., Pineau, C., Silverman, E., Muangchan, C., Peschken, C.A., Lee, J., Lupus, 2013, 10.1177/0961203313505689
  • Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index, Hanly, J.G., Askanase, A., Peschken, C.A., Jacobsen, S., Kalunian, K.C., Kamen, D.L., Ramos-Casals, M., Nived, O., Jonsen, A., van Vollenhoven, R.F., Inanc, M., Lim, S.S., Ruiz-Irastorza, G., Mackay, M., Aranow, C., Zoma, A.A., Manzi, S., Ramsey-Goldman, R., Dooley, M.A., Khamashta, M.A., Petri, M., Alarcón, G.S., Rahman, A., Isenberg, D.A., Bruce, I.N., Urowitz, M.B., Gladman, D.D., Fortin, P.R., Ginzler, E.M., Merrill, J.T., Clarke, A.E., Bernatsky, S., Wallace, D.J., Sanchez-Guerrero, J., Romero-Diaz, J., Gordon, C., Bae, S.-C., Andreou, P., Rockwood, K., Kirkland, S., Legge, A., Arthritis and Rheumatology, 2020, 10.1002/art.41144
  • Challenges of Perceived Self‐Management in Lupus, Murray Rochon, J. Antonio Avina‐Zubieta, Stephanie Keeling, Ann E. Clarke, Janet E. Pope, Mark Matsos, Doug Smith, Marie Hudson, Evelyne Vinet, Christine A. Peschken, Davy Eng, Anna‐Lisa Morrison, Jodie Nimigon‐Young, Wendy Singer, Vinita Haroun, Elham Rahme, Anne‐Sophie Julien, Carolyn Neville, Deborah Da Costa, Paul R. Fortin, Arthritis Care & Research, 2022, 10.1002/acr.24542
  • Quantitative clinical assessment of disease activity in systemic lupus erythematosus: progress report and research agenda, Snaith, L., Isenberg, D.A., Fortin, P.R., Liang, M.H., Rheumatology International, 1991, 10.1007/BF00304502
  • Molecular markers of injury in kidney biopsy specimens of patients with lupus nephritis, Herzenberg, A.M., Scholey, J.W., Yang, S., Fortin, P.R., Wither, J., John, R., Boutros, P.C., Landolt-Marticorena, C., Reich, H.N., Journal of Molecular Diagnostics, 2011, 10.1016/j.jmoldx.2010.10.005
  • Measuring relevant change: an emerging challenge in rheumatologic clinical trials, Katz, J.N., Stucki, G., Fortin, P.R., Arthritis & Rheumatism, 1995, 10.1002/art.1780380802
  • Job accommodations availability and utilization among people with lupus: An examination of workplace activity limitations and work context factors, Fortin, P.R., Su, J., Beaton, D.E., Gignac, M.A.M., Al Dhanhani, A.M., Arthritis Care and Research, 2015, 10.1002/acr.22662
  • Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?, Anis, A.H., Fortin, P.R., Brazier, J.E., Esdaile, J.M., Abrahamowicz, M., Kopec, J.A., Guh, D., Rashidi, A.A., Marra, C.A., Quality of Life Research, 2005, 10.1007/s11136-004-6012-0
  • Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort, Aranow, C., Kalunian, K., Zoma, A., Stoll, T., Ramos, M., Van Vollenhoven, R.F., Dooley, M.A., Ramsey-Goldman, R., Manzi, S., Petri, M., Khamashta, M., Steinsson, K., Nived, O., Sturfelt, G., Bruce, I.N., Merrill, J.T., Alarcón, G.S., Ginzler, E., Wallace, D.J., Sanchez-Guerrero, J., Rahman, A., Isenberg, D., Hanly, J.G., Bernatsky, S., Clarke, A., Gordon, C., Bae, S.C., Fortin, P.R., Ibañez, D., Gladman, D.D., Urowitz, M.B., Arthritis Care and Research, 2012, 10.1002/acr.20648
  • An international perspective on the well being and health care costs for patients with systemic lupus erythematosus, Esdaile, J.M., Ho, V., Danoff, D.S., Grodzicky, T., Choquette, D., Goulet, J.R., Sutcliffe, N., Fortin, P.R., Penrod, J., Joseph, L., St. Pierre, Y., Senecal, J.-L., Gordon, C., Isenberg, D.A., Manzi, S., Petri, M.A., Clarke, A.E., Journal of Rheumatology, 1999
  • Malignancy prevalence in the first-degree relatives of persons with systemic lupus erythematous: A pilot study [1], Fortin, P.R., Boire, G., Rich, E., Peschken, C., Smith, C.D., Hanly, J.G., Pope, J., Clarke, A., Bernatsky, S., Lupus, 2006, 10.1177/0961203306072424
  • α1-antitrypsin deficiency and systemic necrotizing vasculitis, Esdaile, J.M., Watts, C.S., Fraser, R.S., Fortin, P.R., Journal of Rheumatology, 1991
  • Transitioning to employment with a rheumatic disease: The role of independence, overprotection, and social support, Gignac, M.A.M., Mosher, D.P., Tucker, L.B., Rosenberg, A.M., Shiff, N.J., Fortin, P.R., Beaton, D., Badley, E., Jetha, A., Journal of Rheumatology, 2014, 10.3899/jrheum.140419
  • Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus, Fortin, P.R., Clarke, A.E., Neville, C., Bernatsky, S., Pineau, C.A., Chang, E.R., Journal of Rheumatology, 2006
  • Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository, Cohen, H., Pengo, V., Bertolaccini, M.L., Sevim, E., Vega, J., Atsumi, T., Knight, J.S., Rodriguez, E., Cervera, R., Petri, M., Andreoli, L., Fortin, P.R., de Jesus, G., Branch, D.W., Ji, L., Aguirre, M.A., Belmont, H.M., Chighizola, C., Ugarte, A., Tektonidou, M., Qi, M., Romay-Penabad, Z., Borges Galhardo Vendramini, M., Bison, E., Krillis, S., Sciascia, S., Erkan, D., Willis, R., Andrade, D., Lane, P.J., Mackie, I.J., Efthymiou, M., Journal of Thrombosis and Haemostasis, 2019, 10.1111/jth.14596
  • Counterbalancing patient demands with evidence: Results from a Pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus, Clarke, A.E., Gladman, D., St-Pierre, Y., Cividino, A., Smith, D., Rich, E., Choquette, D., Goulet, J.-R., Senécal, J.-L., Zummer, M., Beaulieu, A., Esdaile, J.M., Ensworth, S., Barr, S., Edworthy, S., Fortin, P.R., Joseph, L., Da Costa, D., Dobkin, P.L., Annals of Behavioral Medicine, 2002, 10.1207/S15324796ABM2402_05
  • Measuring clinically important changes with patient-oriented questionnaires., Daltroy, L., Fortin, P.R., Stucki, G., Lew, R.A., Liang, M.H., Medical care, 2002, 10.1097/00005650-200204001-00008
  • Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms, Landolt-Marticorena, C., Boutros, P.C., Fortin, P.R., Scholey, J., Reich, H.N., Avila-Casado, C., Touma, Z., Bonilla, D., Chang, N.-H., Noamani, B., Prokopec, S.D., Wither, J.E., PLoS ONE, 2018, 10.1371/journal.pone.0196117
  • Electrocardiographic findings in systemic lupus erythematosus: Data from an international inception cohort, Pineau, C.A., Zoma, A., Petri, M., Ramos-Casals, M., Kalunian, K., Sturfelt, G., Nived, O., Dooley, M.A., Ginzler, E., Bruce, I.N., Steinsson, K., Alarcón, G.S., Fessler, B., Sanchez-Guerrero, J., Romero-Diaz, J., Merrill, J.T., Fortin, P.R., Gladman, D.D., Rahman, A., Isenberg, D., Gordon, C., Wallace, D.J., Hanly, J.G., Bae, S.-C., Belisle, P., Joseph, L., Huynh, T., Krantz, M.J., Bernatsky, S., Clarke, A.E., Urowitz, M.B., Bourré-Tessier, J., Arthritis Care and Research, 2015, 10.1002/acr.22370
  • Systemic lupus international collaborative clinics: Development of a damage index in systemic lupus erythematosus, Symmons, D., Sturfelt, G., Snaith, M., Sanchez-Guerrero, J., Richter, M., Petri, M., Nived, O., Verrier Jones, J., Isenberg, D., Hay, E., Hanly, J., Bombardieri, S., Bacon, P., Urowitz, M., Liang, M., Fortin, P., Goldsmith, C., Ginzler, E., Gladman, D., Journal of Rheumatology, 1992
  • Discontinuation of antimalarial drugs in systemic lupus erythematosus, Esdaile, J.M., Gans, M., Panaritis, T., Li, Y., Wang, C., Fortin, P.R., Journal of Rheumatology, 1999
  • The frequency and outcome of lupus nephritis: Results from an international inception cohort study, Farewell, V., Thompson, K., Theriault, C., Askanase, A., Jacobsen, S., Peschken, C.A., Maddison, P., Kamen, D.L., Kalunian, K.C., Inanc, M., Stoll, T., Sam Lim, S., Ruiz-Irastorza, G., Ramos-Casals, M., Zoma, A.A., Van Vollenhoven, R.F., Khamashta, M.A., Manzi, S., Sturfelt, G.K., Nived, O., Steinsson, K., Fessler, B.J., Alarcón, G.S., Aranow, C., Ramsey-Goldman, R., Dooley, M.A., Bruce, I.N., Petri, M., Sanchez-Guerrero, J., Gladman, D.D., Fortin, P., Ginzler, E.M., Rahman, A., Isenberg, D.A., Merrill, J.T., Wallace, D.J., Clarke, A.E., Bernatsky, S., Bae, S.-C., Gordon, C., Romero-Diaz, J., Urowitz, M.B., Su, L., O'Keeffe, A.G., Hanly, J.G., Rheumatology (United Kingdom), 2015, 10.1093/rheumatology/kev311
  • Intravenous cyclophosphamide and high dose corticosteroids improve MRI lesions in demyelinating syndrome in systemic lupus erythematosus, Fortin, P.R., Leung, F.K., Journal of Rheumatology, 2003
  • Recruitment strategies in superiority trials in SLE: Lessons from the study of methotrexate in lupus erythematosus (SMILE), Fortin, P.R., Ferland, D., Lupus, 1999, 10.1191/096120399680411371
  • Reply, Lou, W., Jung, H., Fortin, P.R., Arthritis and Rheumatism, 2010, 10.1002/art.27620
  • Canadian rheumatology association recommendations for the assessment and monitoring of systemic lupus erythematosus, Santesso, N., Vinet, E., Touma, Z., Urowitz, M., Suitner, M., Tselios, K., Silverman, E., Reynolds, J., Rader, T., Pope, J., Pineau, C., Peschken, C., Pardi, J.P., Medina-Rosas, J., McDonald, E.G., Matsos, M., Lim, L., Levy, D., Legault, K., Hussein, S., Hiraki, L.T., Hanly, J.G., Haaland, D., Gladman, D.D., Fortin, P.R., Fifi-Mah, A., Ensworth, S., Dutz, J., Baril-Dionne, A., Clarke, A., Bourre-Tessier, J., Bernatsky, S., Bergeron, L., Barr, S., Avina-Zubieta, A., Alabdurubalnabi, Z., Keeling, S.O., Journal of Rheumatology, 2018, 10.3899/jrheum.171459
  • Recent corticosteroid use and recent disease activity: Independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?, Esdaile, J.M., Pineau, C.A., Neville, C., Pilote, L., Fortin, P.R., Abrahamowicz, M., Karp, I., Arthritis Care and Research, 2008, 10.1002/art.23352
  • The relationship between cancer and medication exposures in systemic lupus erythaematosus: A case-cohort study, Clarke, A.E., Ramsey-Goldman, R., Manzi, S., Zummer, M., Sénécal, J.-L., Rajan, R., Dooley, M.-A., Aranow, C., Alarcón, G.S., Petri, M., Rahman, A., Isenberg, D., Edworthy, S., Barr, S., Bae, S.-C., Ginzler, E., Fortin, P.R., Gladman, D., Urowitz, M., Gordon, C., Boivin, J.-F., Joseph, L., Bernatsky, S., Annals of the Rheumatic Diseases, 2008, 10.1136/ard.2006.069039
  • Barriers to healthcare in a multiethnic cohort of systemic lupus erythematosus (SLE) patients: Patient and physician perceptions, Peschken, C., Hudson, M., Chedéville, G., Arbillaga, H., Ramsey, S., Huber, A., Albert, L., Tucker, L., Petty, R., Smith, C.D., Zummer, M., Fortin, P., Cooper, G., Silverman, E., Lalani, S., Pope, J., Law, G., Clinical Medicine: Arthritis and Musculoskeletal Disorders, 2009, 10.4137/cmamd.s2136
  • Breast cancer in systemic lupus, Clarke, A.E., Tessier-Cloutier, B., Raymer, P.C., St Pierre, Y., Hansen, J.E., Foulkes, W.D., Sturfeldt, G., Kamen, D., Aranow, C., Ruiz-Irastorza, G., Witte, T., Joseph, L., Bae, S.-C., Rahman, A., Isenberg, D., Yelin, E.H., Nived, O., Gordon, C., Hanly, J.G., Jacobsen, S., Peschken, C., Romero-Diaz, J., Ginzler, E., Fortin, P.F., Gladman, D.D., Urowitz, M.B., Petri, M., Ramsey-Goldman, R., Bernatsky, S., Lupus, 2017, 10.1177/0961203316664595
  • Randomized feasibility trial of the Scleroderma patient-centered intervention network hand exercise program (SPIN-HAND): Study protocol, Turner, K., Pepin, M.R., Mills, S.D., Levis, B., Jewett, L.R., Gholizadeh, S., Fox, R.S., Cumin, J., Wilcox, P., Varga, J., Thorne, C., Terrier, B., Sutton, E., Steen, V., Spiera, R., Sobanski, V., Smith, D., Smets, P., Roux, S., Rodriguez, E., Robinson, D., Rivière, S., Régent, A., Paule, R., Mekinian, A., Maurier, F., Masetto, A., Martin, T., Martin, M., Manning, J., Luna, D., London, J., Liang, P., Launay, D., Lambert, M., Korman, B., Khalidi, N., Kafaja, S., Fernandes, A.J.B., Jones, N., Ikic, A., Hinchcliff, M., Hij, A., Herrick, A.L., Hatron, P.-Y., Hachulla, E., Gyger, G., Grange, C., Granel-Rey, B., Gordon, J., Gill, A., Fortin, P.R., Farge-Bancel, D., Fare, R., Dunne, J.V., Domsic, R., Denton, C., Dagenais, P., Cohen, P., Chung, L., Chaigne, B., Casadevall, M., Carreira, P., Bruns, A., Boire, G., Bissonnette, L., Berthier, S., Benzida, I., Benmostefa, N., Arsenault, G., André, M., Albert, A., Agard, C., Wong-Rieger, D., Suarez-Almazor, M.E., Steele, R.J., Reyna, T.S.R., Portales, A., Pope, J., Nielsen, K., Marra, C., Leite, C., Larche, M., Körner, A., Kennedy, A.T., Johnson, S.R., Jang, Y., Impens, A., Harel, D., Godard, D., Frech, T., Fortune, C., Fligelstone, K., Ells, C., El-Baalbaki, G., Maia, A.C., Assassi, S., Wigley, F., Riggs, R., Nielson, W.R., Mayes, M.D., Malcarne, V., van den Hoogen, F., Gottesman, K., Furst, D., Bartlett, S.J., Baron, M., Mouthon, L., Thombs, B.D., Hudson, M., Schouffoer, A.A., van den Ende, C., Sauve, M., Welling, J., Boutron, I., Kwakkenbos, L., Carrier, M.-E., Journal of Scleroderma and Related Disorders, 2018, 10.5301/jsrd.5000263
  • Using Marital Status and Continuous Marital Satisfaction Ratings to Predict Depressive Symptoms in Married and Unmarried Women With Systemic Sclerosis: A Canadian Scleroderma Research Group Study, Fortin, P., Thorne, C., LeClercq, S., Mittoo, S., Grodzicky, T., Ligier, S., Mathieu, J.-P., Docherty, P., Kaminska, E., Jones, N., Robinson, D., Khalidi, N.A., Sutton, E., Masetto, D.A., Pope, J., Thombs, B.D., Baron, M., Hudson, M., Hagedoorn, M., Steele, R.J., Kwakkenbos, L., Rice, D.B., Levis, B., Arthritis Care and Research, 2016, 10.1002/acr.22802
  • Expanded population of activated antigen-engaged cells within the naive B cell compartment of patients with systemic lupus erythematosus, Wither, J.E., Urowitz, M., Gladman, D., Fortin, P.R., Landolt-Marticorena, C., Bonventi, G., McKenzie, T., Chang, N.-H., Journal of Immunology, 2008, 10.4049/jimmunol.180.2.1276
  • Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: Data from an international inception cohort, Bruce, I.N., Inanc, M., Peschken, C.A., Kamen, D.L., Lim, S.S., Ruiz-Irastorza, G., Kalunian, K.C., Van Vollenhoven, R.F., Ramos-Casals, M., Mackay, M., Aranow, C., Nived, O., Sturfelt, G.K., Zoma, A.A., Ramsey-Goldman, R., Khamashta, M.A., Manzi, S., Dooley, M.A., Steinsson, K., Petri, M., Hanly, J.G., Fortin, P.R., Fessler, B.J., Alarcón, G.S., Merrill, J.T., Rahman, A., Isenberg, D.A., Ginzler, E.M., Bernatsky, S., Clarke, A.E., Wallace, D.J., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Bae, S.-C., Donn, R., Lunt, M., Gladman, D.D., Urowitz, M.B., Parker, B., Annals of the Rheumatic Diseases, 2015, 10.1136/annrheumdis-2013-203933
  • Alpha2beta1 integrin (VLA-2) protects activated human effector T cells from methotrexate-induced apoptosis, Aoudjit, F., Fortin, P.R., Naci, D., El Azreq, M.-A., Abderrazak, A., Frontiers in Immunology, 2018, 10.3389/fimmu.2018.02269
  • The needs of persons with lupus and health care providers: A qualitative study aimed toward the development of the Lupus Interactive Navigator™, Fortin, P.R., Eng, D., Pineau, C.A., Aviña-Zubieta, J.A., Rochon, M., Mill, C., Costa, D.D., Neville, C., Lupus, 2014, 10.1177/0961203313517154
  • Association of health-related quality of life in childhood-onset systemic lupus erythematosus with ethnicity: Results from a multiethnic multicenter canadian cohort, Moyen, M., Craig, A., Hitchon, C., Ouimet, J., Hewitt, S., Hanly, J., Bernstein, J., Berkson, L., Baron, M., Hudson, M., Wehlage, A., Arbillaga, H., Ferland, D., Zummer, M., Smith, K., Simpson, S., Smith, C.D., Santopietro, T., Tobaly, M., Bernatsky, S., Pineau, C., Clarke, A., McKenzie, T., Inman, R., Carette, S., Albert, L., Gladman, D., Urowitz, M., Fortin, P., Ng, L., Warner, A., Ramsey, S., Lang, B., Scuccimarri, R., Duffy, K., Campillo, S., Morishita, K., Houghton, K., Cabral, D., Petty, R., Silverman, E.D., Pope, J.E., Huber, A.M., Chédeville, G., Tucker, L.B., Peschken, C.A., Levy, D.M., Arthritis Care and Research, 2014, 10.1002/acr.22363
  • The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus, Fortin, P.R., Mayo, N.E., Wang, C., Journal of Rheumatology, 2001
  • Enhanced myelopoiesis and aggravated arthritis in S100a8-deficient mice, Tessier, P.A., Pelletier, M., Aoudjit, F., Labrecque, N., Daudelin, J.-F., Fortin, P.R., Oravecz, T., Al-Shami, A., Tardif, M.R., Pagé, N., Lachhab, A., Defrêne, J., Cesaro, A., PLoS ONE, 2019, 10.1371/journal.pone.0221528
  • Assessment of the educational impact of an information leaflet on the knowledge of complications in systemic sclerosis,Évaluation de l'impact d'une brochure d'information sur la connaissance des complications dans la sclérodermie systémique, Michou, L., Fortin, P.R., Bessette, L., Brown, J.P., Beaudoin, C., Ikic, A., Revue du Rhumatisme (Edition Francaise), 2015, 10.1016/j.rhum.2015.04.001
  • Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysis, Whitehead, N., Phillips, M.J., Levine, S.R., Kosinski, A.S., Haywood, N., Garcia, D., Fortin, P.R., Erkan, D., Crowther, M., Catellier, D., Meleth, S., Ortel, T.L., Journal of Thrombosis and Haemostasis, 2020, 10.1111/jth.14936
  • Patients with systemic autoimmune diseases could not distinguish comorbidities from their index disease, Baron, M., Wither, J., Fortin, P.R., Taillefer, S., Bernatsky, S., Hudson, M., Journal of Clinical Epidemiology, 2008, 10.1016/j.jclinepi.2007.08.010
  • SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus, Farewell, V., Kalunian, K., Zoma, A., Ramos-Casals, M., Van Vollenhoven, R., Aranow, C., Dooley, M.A., Ramsey-Goldman, R., Sturfelt, G., Nived, O., Manzi, S., Petri, M., Fessler, B., Alarcón, G.S., Khamashta, M., Steinsson, K., Bruce, I.N., Gladman, D.D., Fortin, P.R., Merrill, J.T., Romero-Diaz, J., Sanchez-Guerrero, J., Rahman, A., Isenberg, D., Vasudevan, A., Bernatsky, S., Clarke, A., Wallace, D.J., Gordon, C., Bae, S.C., Jackson, D., Urowitz, M.B., Hanly, J.G., Annals of the Rheumatic Diseases, 2011, 10.1136/ard.2010.138792
  • Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus, Farewell, V., Thompson, K., Douglas, J., Zoma, A., Ramos-Casals, M., Kalunian, K., Aranow, C., Sturfelt, G., Nived, O., Van Vollenhoven, R., Ramsey-Goldman, R., Dooley, M.A., Manzi, S., Petri, M., Khamashta, M., Steinsson, K., Bruce, I.N., Ginzler, E., Merrill, J.T., Romero-Diaz, J., Sanchez-Guerrero, J., Fortin, P.R., Gladman, D.D., Rahman, A., Alarcón, G.S., Isenberg, D., Bernatsky, S., Clarke, A., Wallace, D.J., Gordon, C., Bae, S.C., Su, L., Urowitz, M.B., Hanly, J.G., Annals of the Rheumatic Diseases, 2010, 10.1136/ard.2008.106351
  • Steroid-sparing effects of methotrexate in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled trial, Zummer, M., Smith, C.D., Lacaille, D., Ferland, D., Abrahamowicz, M., Fortin, P.R., Arthritis Care and Research, 2008, 10.1002/art.24068
  • Fatal pulmonary venoocclusive disease secondary to a generalized venulopathy: A new syndrome presenting with facial swelling and pericardial tamponade, Murphy, G., Mudge, G.H., Marsh, J.D., Louie, D.C., Fortin, P.R., Stern, S., Liang, M.H., Arthritis & Rheumatism, 1991, 10.1002/art.1780340217
  • The scleroderma patient-centered intervention network cohort: Baseline clinical features and comparison with other large scleroderma cohorts, Turner, K., Persmann, J., Pepin, M.R., Mills, S.D., Levis, B., Jewett, L.R., Gholizadeh, S., Fox, R.S., Fedoruk, C., Delisle, V.C., Cumin, J., Wong-Rieger, D., Wigley, F., Welling, J., Varga, J., Suarez-Almazor, M.E., Steele, R.J., Smith, D., Schouffoer, A.A., Roux, S., Reyna, T.S.R., Robinson, D., Riggs, R., Portales, A., Nielsen, K., Masetto, A., Marra, C., Liang, P., Leite, C., Korman, B., Khalidi, N., Kennedy, A.T., Fernandes, A.J.D.B., Jang, Y., Impens, A., Ikic, A., Harel, D., Gyger, G., Godard, D., Fortune, C., Fligelstone, K., Van Den Ende, C., Ells, C., El-Baalbaki, G., Domsic, R., Dagenais, P., Maia, A.C., Carreira, P., Boutron, I., Bissonette, L., Arsenault, G., Albert, A., Mayes, M.D., Thombs, B.D., Wilcox, P., Thorne, C., Sutton, E., Steen, V., Spiera, R., Pope, J., Manning, J., Larché, M., Kafaja, S., Jones, N., Johnson, S.R., Hudson, M., Hinchcliff, M., Herrick, A.L., Gordon, J., Gill, A., Frech, T., Fortin, P., Dunne, J.V., Denton, C., Chung, L., Bruns, A., Boire, G., Sauvé, M., Poiraudeau, S., Nielson, W.R., Mouthon, L., Malcarne, V.L., Van Den Hoogen, F., Gottesman, K., Furst, D.E., Bartlett, S.J., Baron, M., Assassi, S., Salazar, G., Carrier, M.-E., Kwakkenbos, L., Dougherty, D.H., Rheumatology (United Kingdom), 2018, 10.1093/rheumatology/key139
  • Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort, Vinet, E., Costedoat-Chalumeau, N., Bruce, I.N., Sanchez-Guerrero, J., Askanase, A., Jacobsen, Sø., Peschken, C.A., Kamen, D.L., Inanc, M., Kalunian, K.C., Lim, S., Ruiz-Irastorza, G., Ramos-Casals, M., Van Vollenhoven, R.F., Zoma, A.A., Jönsen, A., Nived, O., Manzi, S., Alarcón, G.S., Mackay, M., Aranow, C., Khamashta, M.A., Ramsey-Goldman, R., Steinsson, K., Gladman, D.D., Fortin, P.R., Dooley, M.A., Petri, M., Ginzler, E.M., Rahman, A., Isenberg, D.A., Buyon, J.P., Merrill, J.T., Wallace, D.J., Bae, S.-C., Gordon, C., Romero-Diaz, J., Clarke, A.E., Urowitz, M.B., Hanly, J.G., Bernatsky, S.B., Mendel, A., Annals of the Rheumatic Diseases, 2019, 10.1136/annrheumdis-2018-214434
  • Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study, Farewell, V., Thompson, K., Qiufen Qi, K., Douglas, J., Kalunian, K., Ramsey-Goldman, R., Sturfelt, G., Nived, O., Ginzler, E., Aranow, C., Van Vollenhoven, R., Font, J., Zoma, A., Khamashta, M., Manzi, S., Bruce, I.N., Petri, M., Steinsson, K., Gladman, D., Fortin, P.R., Dooley, M.A., Bernatsky, S., Clarke, A., Merrill, J.T., Alarcón, G.S., Isenberg, D., Wallace, D.J., Gordon, C., Bae, S.C., Sanchez-Guerrero, J., Su, L., Urowitz, M.B., Hanly, J.G., Arthritis Care and Research, 2008, 10.1002/art.23566
  • A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles, Rioux, J.D., Wither, J., Fortin, P.R., Zummer, M., Barr, S.G., Boire, G., Rich, E., Hanly, J., Smith, C.D., Peschken, C., Pope, J.E., Clarke, A.E., Gladman, D., Hudson, T., Claudio, J.O., Graham, R.R., Lian, J., Boucher, G., Goyette, P., Budarf, M.L., Genes and Immunity, 2011, 10.1038/gene.2010.47
  • Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience, Évelyne Vinet, Sasha Bernatsky, Daniel J Wallace, Murray Urowitz, Jorge Sanchez-Guerrero, Anisur Rahman, Michelle Petri, Marta Mosca, Anselm Mak, David Alan Isenberg, Murat Inanç, John G Hanly, Rosalind Ramsey-Goldman, Dafna D Gladman, Paul R Fortin, Nathalie Costedoat-Chalumeau, Ann Elaine Clarke, Jill P Buyon, Sang-Cheol Bae, Anca Askanase, Arielle Mendel, Joo-Young E Lee, Annals of the Rheumatic Diseases, 2023, 10.1136/ard-2023-224197
  • Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: The patient perspective, Penrod, J.R., Donaldson, C., Menard, H.A., Fortin, P.R., Panaritis, T., St-Pierre, Y., Adam, V., Guillemin, F., Clarke, A.E., Fautrel, B., Journal of Rheumatology, 2005
  • The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus, Fortin, P.R., Lou, W., Urowitz, M., Gladman, D.D., Shariati-Sarabi, Z., Su, J., Bobba, R., Jung, H., Arthritis and Rheumatism, 2010, 10.1002/art.27289
  • Association of LY9 in UK and Canadian SLE families, Rioux, J.D., Wither, J., Greenwood, C.M.T., Terhorst, C., Sharpe, A., Hudson, T.J., Chad, L., Rhodes, B., Farwell, L., McKenzie, T., Lim, S., Cai, Y.-C., Montpetit, A., Fortin, P.R., Vyse, T.J., Graham, D.S.C., Genes and Immunity, 2008, 10.1038/sj.gene.6364453
  • Non-lymphoma hematological malignancies in systemic lupus erythematosus, Clarke, A.E., Lee, J.L., Dreyer, L., Sturfelt, G., Criswell, L.A., Gottesman, L., Nived, O., Alarcón, G.S., Peschken, C.A., Dooley, M.A., Jacobsen, S., Wallace, D.J., Bae, S.-C., Yelin, E., Ginzler, E.M., Fortin, P.R., Gladman, D., Urowitz, M.B., Manzi, S., Petri, M., Ramsey-Goldman, R., Bernatsky, S., Lu, M., Oncology (Switzerland), 2013, 10.1159/000350165
  • Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices, Fortin, P.R., Neville, C., Bélisle, P., Joseph, L., Danoff, D.S., Clarke, A.E., Moore, A.D., Journal of Rheumatology, 1999

Contribution à l'enseignement aux cycles supérieurs

Étudiant(e)s dirigé(e)s*

Depuis 2009
  • Yaneisy-Nynoska Tremblay - Maîtrise avec mémoire - En cours
  • Sandrine Huot - Doctorat - En cours
  • Laurence Mainville - Maîtrise avec mémoire - 2021/09
  • Alix St-Aubin - Maîtrise avec mémoire - 2022/01
*Les supervisions d’étudiant(e)s de 1er cycle en stage de recherche et de résident(e)s aux études médicales postdoctorales seront répertoriées ultérieurement.